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ABSTRACT 
The healthy aging index (HAI) is a score variable based on five clinical 
components. I assess how well it predicts mortality in a sample of older adults 
from the Framingham Heart Study (FHS). Over 30% of FHS participants have 
missing HAI across time; I investigate how well imputation methods perform in 
this setting. I run simulations to compare four methods of multiple imputation (MI) 
by fully conditional specification (FCS) and the complete case (CC) approach on 
estimation of means, correlations, and slopes of the HAI over time. I simulate 
multivariate normal data for each component of HAI at four time points, along 
with age and sex, using within and across-time correlation patterns at the percent 
of missing data seen in observed FHS data. My methods of MI are cross-
sectional FCS (XFCS, imputation model uses other components at same time), 
longitudinal FCS (LFCS, uses same component at all times ignoring cross-
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component correlation), all FCS (AFCS, uses all components at all times) and 2-
fold FCS (2fFCS, uses all components at current and adjacent times). I compare 
percent bias, confidence interval width, coverage probability and relative 
efficiency for three mechanisms of missing data (MCAR,MAR,MNAR), two 
sample sizes (n=1000,100), and two numbers of imputed datasets (m=5,20). All 
longitudinal methods (not XFCS) yield nearly identical results with unbiased 
estimates of means, correlations and slopes. Increase in precision and relative 
efficiency is small when augmenting from 5 to 20 imputations. 
Finally, I compare the imputation methods and CC analysis in survival models 
using HAI as a time-dependent variable to predict mortality. I simulate HAI data 
as described above, time-to-death using piece-wise exponential models, and I 
impose type I and random censoring on 32% of observations. CC analysis 
reduces sample size by 10%, produces unbiased estimates, but inflates standard 
errors. The three longitudinal imputation methods introduce minimal bias (<5%) 
in the hazard ratio estimates, while reducing the standard error up to 10% 
compared with CC. 
Overall, I show that multiple imputation using longitudinal methods is 
beneficial in the setting of repeated measurements of a score variable. It works 
well in analyzing changes over time and in time-dependent survival analyses. 
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CHAPTER 1 - INTRODUCTION 
Missing Data 
Missing data is a problem in most clinical studies. Data can be missing for 
many reasons including - but not limited to - subjects randomly dropping out of 
studies prior to the planned end of follow-up, subjects choosing to discontinue 
prematurely from a clinical trial because the randomized treatment is not 
effective, or death. Sometimes the fact that the data are missing is non-
informative, in which case the missing data can be ignored and analyses can be 
done on the complete cases (albeit, with loss of efficiency). Other times there is 
informative missing data, where the statistical analyses must account for the 
missing data in order to reduce bias in estimates that may come from ignoring 
missing data. Many methods exist to account for missing data in statistical 
analysis, but the most appropriate method depends on the missing data 
mechanism (which usually cannot be verified) and statistical methodology to be 
used to analyze the data. I examined the properties of various imputation 
methods on healthy aging index (HAI) data, a composite score developed to 
measure subclinical disease in older populations, as collected on participants of 
the Framingham Heart Study (FHS). 
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Healthy Aging Index 
The motivation behind this dissertation was the use of the HAI to predict 
mortality and cardiovascular disease (CVD) risk in the FHS Offspring cohort. The 
HAI was developed in epidemiologic studies using noninvasive measures 
intended to capture subclinical disease status across multiple organ systems.1 It 
comprises information from five physiologic systems: cardiovascular measured 
by systolic blood pressure (SBP); metabolic represented by fasting glucose; 
kidney measured by creatinine; brain evaluated by Mini-Mental State Exam 
(MMSE); and pulmonary explained by forced vital capacity (FVC). Data values 
for each component are arranged into three ordinal groups; the least healthy 
group is assigned a score of 2, the middle group a score of 1, and the healthiest 
group a score of 0. The component scores are summed to create the HAI, 
ranging from 0 (healthiest) to 10 (least healthy). 
In the Cardiovascular Health Study (CHS) and Long Life Family Study2, 
Sanders et al2 assigned patients to one of the three groups. For each 
component, they used the following methods: clinical cut-points for glucose; 
tertiles from their samples for SBP and MMSE; and sex-specific tertiles from their 
samples for FVC and serum creatinine, as little overlap existed in the values 
between men and women for these measures. Participants using related 
medications or who had previously reported being diagnosed with a relevant 
disease were assigned a score of 2 for that component. For the FHS Offspring 
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cohort, we used the same cut-points to define risk groups as Sanders et al.2 The 
HAI score has previously been analyzed per unit of index as well as in a 
categorical variable with groups 0-2 (reference), 3-4, 5-6, and 7-10.1-4 
The HAI is positively associated with mortality and disability, and negatively 
associated with longevity in the CHS1-3 and the Health, Aging, and Body 
Composition Study.3 Both studies were conducted using participants with 
advanced age (CHS is 65+ with average age of 75, and Health, Aging and Body 
Composition Study is 70-79 years old with average age of 74) and fairly 
symmetric HAI values (i.e., few participants were characterized as very healthy 
or very unhealthy). In the FHS Offspring cohort, the HAI components are 
available at examinations 5-8. At exam 5, the individuals in the FHS Offspring 
study are approximately ten years younger, on average (66±5 years), than the 
participants in the previous HAI studies. 
Missing data on HAI components is a frequently encountered problem. For 
example, Sanders et al. reported 31% of the sample missing HAI in the CHS2; in 
FHS, 20-30% of the HAI data are missing at each exam, and only 35% of the 
FHS sample has complete HAI data. There are most likely multiple mechanisms 
causing missing HAI data. 
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Literature Review 
Mechanisms of Missing Data 
We expect some missing data in studies of human subjects. Using capital 
letters to represent random variables, and lower case letters to indicate their 
realized values, the set of all data are denoted as the n x 1 vector 𝒀. 𝒀 is 
partitioned into observed (𝒀𝒐) and missing (𝒀𝒂) data such that 𝒀 = {𝒀𝒐, 𝒀𝒂}. For 
each observation 𝑌 ∈ 𝒀, there is a missing value indicator R, such that 𝑅 =
{1, 𝑌 𝑜𝑏𝑠𝑒𝑟𝑣𝑒𝑑;  0, 𝑌 𝑚𝑖𝑠𝑠𝑖𝑛𝑔}.5 
Little and Rubin6 described the three mechanisms of missing data. Data are 
missing completely at random (MCAR) if the missingness of the data does not 
depend on the values of the data. This is denoted as Pr(𝒓|𝒚𝒐, 𝒚𝒂) = Pr(𝒓). 
Missing at random (MAR) means that the value of the missing data depends only 
on the observed data, or Pr(𝒓|𝒚𝒐, 𝒚𝒂) = Pr(𝒓|𝒚𝒐). Finally, missing not at random 
(MNAR) indicates that the missingness of the data depends on the value of the 
missing data. MNAR is assumed when neither MCAR nor MAR hold.4 Further, if 
data are not MCAR, it is impossible to determine whether data are MAR or 
MNAR, as it requires unverifiable assumptions about the data. 
Overview of Multiple Imputation 
Single imputation involves filling in a single value for each missing value prior 
to carrying out the main analyses. The advantages are that it is very simple to 
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implement and once implemented, we can use complete-data methods on the 
filled-in dataset, and the imputing only needs to be done once. The 
disadvantages are that the resulting estimates can be biased, and it does not 
reflect the uncertainty due to sampling or comparing different models, hence 
potentially underestimating the variance of the estimates.7 
Multiple imputation (MI) was introduced by Rubin6-8 more than 30 years ago 
as a better way of dealing with data that are MAR. Rather than filling in a single 
value for each missing data point, MI creates 𝑚 complete datasets. In each 
complete dataset, the missing values are filled in by random draws from a 
distribution of plausible values.9 Rubin discusses the advantages of MI over 
single imputation: 1) MI increases the efficiency of estimation; 2) MI allows for 
combining results from complete-data methods, which produces inferences that 
account for the variability in non-response; and 3) MI is straightforward to employ 
for studying the effect of various models on the inferences. 
Methods of Multiple Imputation 
Many methods of MI have been developed since Rubin first introduced MI 
over 30 years ago. Two of the most widely used methods are Markov Chain 
Monte Carlo (MCMC) and fully conditional specification (FCS). Both of these 
methods are available in many software packages, making them easily 
accessible to programmers and analysts. I briefly summarize these two methods, 
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as well as an extension of FCS used for longitudinal data called two-fold FCS 
(2fFCS). 
Markov Chain Monte Carlo (MCMC) 
MCMC and the progression of computing environments made it possible to 
generate multiple imputations in a multivariate setting efficiently.10 Shafer first 
published this method in 1997, and it is now widely available in many software 
packages. The method assumes multivariate normality and imputes missing data 
for all variables simultaneously using a two-step iterative stochastic procedure. 
The imputation, or I-step, involves simulating random normal vectors for each 
observation independently using the estimated mean and covariance matrix, and 
the current (or initial) parameter estimate, 𝜽(𝒕), from the conditional distribution 
Pr (𝒀𝒂|𝒀𝒐, 𝜽
(𝒕)). The posterior, or P-step, simulates the posterior mean and 
covariance matrix, 𝜽(𝑡+1), from the complete sample Pr (𝜽|𝒀𝒐, 𝒀𝒂
(𝒕+𝟏)). The new 
estimates are used in the I-step, and the process is iterated until the results 
converge to a stationary distribution.11 The MCMC imputation method is 
generally robust to departures from normality, and techniques like normalization 
can be performed prior to imputation to make the data more normal.12 
Fully Conditional Specification (FCS) 
MI using chained equations, or FCS, was implemented independently by van 
Buuren et al.13 and Raghunathan et al.14 as a solution for imputing missing data 
in datasets with a large number of variables, where traditional MI methods are 
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too computationally intensive, without the restriction of imposing multivariate 
normality. Imputing data conditionally using MCMC on all observed information 
yields unbiased estimates with desirable sampling properties,14 but is not always 
feasible in very large datasets. FCS is a more flexible method that allows each 
variable with missing data to be imputed with a potentially different set of 
specified variables and different types of regression (e.g., linear, logistic, ordered 
logistic, etc.). Lee and Carlin12 showed through a simulation study with data 
missing on multiple covariates that FCS yields similar bias, confidence interval 
coverage, and precision as multivariate normal imputation (MCMC) in a standard 
regression analysis.  
Two-fold Fully Conditional Specification (2fFCS) 
Nevalainen et al. extended standard FCS to a repeated measurements 
setting with the possibility of non-monotone missing data patterns in time-
dependent covariates by creating the 2fFCS.15 The 2fFCS accounts for missing 
individual measures within each follow-up time, and for subjects missing 
completely at certain times due to non-attendance, with a doubly iterative 
procedure. The algorithm does bw within-time iterations (for each variable at time 
i), followed by ba among-time iterations (second imputation iteration among index 
i). One drawback to this method is that once it reaches a certain time point, the 
imputations for that time begin again from the starting values rather than using 
the previously imputed values due to constraints in the IVEware software 
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Nevalainen used to implement the method. This nonparametric method is 
computationally intensive, so they used a variable selection procedure prior to 
imputation, similar to FCS. Nevalainen et al. used simulations to determine 
appropriate values for bw (10 vs 50) and ba (1 vs 5) and to evaluate the impact of 
the variable selection procedure in a dataset where individuals had all 
measurements at a given time point masked MAR. The motivating dataset 
contained measurements at three time points and had up to 40% missing data in 
samples of size n=1000. The authors compared bias, relative efficiency and 
coverage probability between 2fFCS and CC analysis to assess 2fFCS 
performance.15 They found that 2fFCS leads to valid statistical inferences, with 
acceptably small bias. They also advise using more within-time and among-time 
iterations when it is computationally feasible; however, the gain in using more 
was surprisingly small. 
Welch et al. extended Nevalainen’s approach to include more than three time 
points, to allow for a higher percentage of missing data, to include an additional 
step that imputes time independent variables, and to allow imputation of time-to-
event data.16 In simulations, they generated data for several risk factors for 
coronary heart disease, as well as the outcome, coronary heart disease, using 
exponential time-to-event model, with hazard depending on the health indicator 
values at the first time point. They justified using event indicator and time instead 
of cumulative hazard because the data were generated from an exponential 
model where cumulative hazard is proportional to time. They masked data for 
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multiple health indicator covariate values using MCAR missing data mechanism. 
They compared three different imputation approaches: all FCS (AFCS), cross-
sectional FCS (XFCS) and 2fFCS. In the AFCS imputations, they applied 
standard FCS to data at all time blocks. Unfortunately, this method failed to run 
successfully on 25% of data sets due to collinearity issues, so this method was 
ignored in comparisons. The XFCS imputations applied standard FCS to data at 
the baseline time block only, and the 2fFCS imputations were run as described 
above with bw = 5 and ba = 20. They used efficiency (ratio of empirical variance of 
the full data estimator to the partial data estimators) and coverage of confidence 
intervals to compare imputation methods. Their motivating dataset had ten time 
points, and missing data were MCAR with up to 70% of the data missing.16 Their 
results indicate that 2fFCS performs better than XFCS especially when 
correlation within and between variables is strong. 
Using Imputed Data in Statistical Analyses 
Once the 𝑚 complete datasets are created and analyzed using complete-data 
methods, the inferences are combined across the complete datasets using a set 
of rules Rubin developed to generate one overall inference.7 The point estimate 
is the average of the complete-data point estimates, and we calculate the 
variance using the within-imputation variance (average of the complete-data 
variance estimates) and the between-imputation variance (variance of the 
complete-data point estimates). In the past 30 years, MI has been studied in a 
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multitude of settings, including methods for imputing data for ordinal scale 
variables,17,18 for survival analysis,16,19,20 and in longitudinal settings;15,16,21,22 
however, to my knowledge there is a gap in the literature regarding how to 
handle all of these situations at once. 
Item-level vs Scale-level Imputation 
When a variable is a composite of several other variables, we can impute the 
missing original variables individually (item-level) prior to creating the composite 
variable, or we can directly impute the missing composite variable itself (scale-
level). Item-level imputation typically incorporates other observed item-level 
responses in the imputation model, and these tend to be stronger correlates of 
the incomplete variable than scale-level imputation, which uses other observed 
scale-level responses. However, scale-level imputation may be more reasonable 
in studies with several multiple-item measures where imputing at the item-level 
may cause convergence problems when the ratio of variables to sample size is 
too large. The general recommendation is to impute variables at the item-
level.17,18,23 
Gottschall et al. did a simulation study to compare item- and scale-level 
imputation approaches. Their simulated data contained several composite 
variables (scales). For the MI, the item-level imputation model included all 
observed item-level responses, and the scale-level imputation model included all 
observed scale-responses (but did not include observed item-level responses 
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within the scale that is missing). In addition to varying the imputation approach, 
they also looked at rate of item-level missing data (5% or 15%), number of scales 
(3 or 6), magnitude of between-scale correlations (r=0.1 or 0.5), number of items 
per scale (3 or 12), homogeneity of within-scale correlations (uniform, moderate 
homogeneity, low homogeneity) and sample size (N=200, 400 or 800). 
They used a factor analysis model as the data-generating population model, 
and an auxiliary variable to represent the cause of missing data when masking 
data MAR. They used continuous imputations and did not force the imputed 
values to be integers. Bias, mean square error (MSE), confidence interval width 
and power were used to evaluate the parameter estimates, with Cohen’s small 
effect size benchmark as a guide to determine which design effects should be 
interpreted. There was a minimal amount of bias using both item-level and scale-
level imputation approaches. Item-level imputation had much better precision 
than scale-level imputation. The authors suggest implementing item-level 
imputation whenever possible (i.e. when the sample size is large enough).17 
Similarly, Carpenter and Kenward discuss scale-level variables that comprise 
answers to a series of questions organized within several domains. The scale-
level variable is created by summing items within each domain and then across 
domains for a total score, as illustrated with the SF-36 test for state of health.18 
They discuss a simple example with L binary responses for each of J domain 
scores measured in n individuals. They recommend imputing missing domain 
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averages, calculated by averaging the binary response to each question within 
the domain, using a multivariate normal distribution with completely observed 
domain averages in the imputation model. They incorporate partially observed 
data by calculating a range of plausible scores and using them as bounds for 
imputed values. However, since the HAI is comprised of five continuous 
components, I cannot apply this method directly to our current approach of 
imputing each component on its original scale. 
Survival Models 
It is the general consensus that, when using MI on covariates with missing 
values in time-to-event analysis, the imputation model should contain information 
about both the event and the time-to-event.18-20,24 The recommendation of what 
variable to use to capture time-to-event has evolved over time. White and 
Royston considered the case of missing covariates when event or censoring 
time, T, and the event indicator are observed, and they recommend using an 
event indicator, cumulative baseline hazard H0(T), and other covariates to impute 
missing covariates for a Cox regression model. They show that using log(T) 
instead of H0(T) produces biased estimates of covariate-outcome associations. If 
H0(T) is unknown, we can use the Nelson-Aalen estimator or Cox regression to 
estimate it.20 Carpenter and Kenward agree that this approach works as well, if 
not better, than other proposed methods when the proportional hazards 
assumption is met.18 
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Thesis 
This thesis explores the complex problem of how to handle a large amount of 
data missing due to multiple mechanisms in longitudinal analyses for a score 
variable such as the HAI. The motivation for this thesis began with a series of 
papers showing an association between the HAI and mortality in populations of 
older adults (aged 65+ with average age of about 75 years).1-3 In these studies, 
the researchers used baseline HAI measurements with 9-15 years of follow-up in 
Cox proportional hazards models. Here, I tackle a broader problem, extending 
the literature to assess if an association between the HAI and mortality exists in a 
slightly younger population (aged 60+, with average age of 66 years), and 
incorporating longitudinal HAI data measurements. I generalize the statistical 
methods by looking at how the HAI changes over time, and using it as a time-
dependent covariate in Cox proportional hazards models for mortality. 
I begin with the motivating problem, assessing if the association previously 
seen between the HAI and mortality in an older population also exists in a 
sample of individuals in earlier old age to see if HAI can be used as a predictor of 
mortality earlier in life. I also investigate how MI performs in a study of older 
adults, where, to my knowledge, MI has never been used in studies of the HAI.1-3 
Then, in a more general setting, I investigate imputation methods for missing 
HAI data in analyses of correlation and linear mixed effects (LME) models 
through a simulation study based on FHS Offspring cohort data, and then I apply 
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the imputation methods to the motivating FHS Offspring cohort data. I use four 
different MI methods to handle missing longitudinal HAI data. All four methods 
are based on FCS, a flexible, popular, and widely available method that would be 
easy to implement in studies of older adults. Three of the methods use traditional 
FCS, varying which HAI components and time points are used in the imputation 
model. The fourth method is 2fFCS. 
I use the available longitudinal HAI information in survival analyses by treating 
HAI as a time-dependent covariate, investigating the strengths of my MI methods 
in a simulation study. Finally, I apply the MI methods in the motivating FHS 
Offspring cohort data.
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CHAPTER 2 – HEALTHY AGING INDEX IN THE FRAMINGHAM HEART 
STUDY: A MOTIVATING EXAMPLE 
Introduction 
The healthy aging index (HAI), a modified version of the physiologic index of 
comorbidity,1 was developed in epidemiologic studies using noninvasive 
measures across multiple organ systems.2,3 The HAI score, which ranges from 0 
(most healthy) to 10 (least healthy), is associated positively with mortality and 
disability in the Cardiovascular Health Study (CHS) and Health, Aging, and Body 
Composition Study,1-3 and negatively with longevity in the Long Life Family 
Study.2 All of these studies were conducted using participants with advanced old 
age and fairly symmetric HAI values (i.e., few participants were characterized as 
very healthy or very unhealthy). 
We examined the association of the HAI with all-cause mortality and incident 
cardiovascular disease (CVD) and cancer in a sample of participants in earlier 
old age from the Framingham Heart Study (FHS) Offspring Cohort. We 
hypothesized that participants with higher scores, indicating a greater burden of 
disease across multiple physiologic systems, would not only have increased 
mortality, but a higher incidence of CVD and cancer, the two leading causes of 
death in older adults. We assessed how including C-reactive protein (CRP), an 
established marker of systemic inflammation,25 and resting heart rate, a 
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recognized measure of overall autonomic function and physical fitness,26 in the 
HAI may modify the observed associations between the HAI and mortality or 
CVD. CRP is particularly interesting because chronic inflammation is considered 
a marker of biological aging across multiple organ systems27 and is a common 
pathway to all-cause mortality.28,29 Finally, we examined if multiple imputation 
methods are appropriate to increase sample size for the HAI in this study of older 
participants under longitudinal follow-up. Missing data is a common problem, with 
up to 31% of the sample missing an individual component in prior reports.2 
Methods 
Study Sample 
The FHS Original Cohort participants were enrolled, beginning in 1948, to 
study risk factors for CVD. In 1971, the Offspring and Offspring spouses of the 
Original cohort were enrolled in the Framingham Offspring Study; they have been 
examined every 4 to 8 years.30 Of 3799 Framingham Offspring participants who 
attended the fifth examination cycle (1991-1995), 1348 were at least 60 years of 
age and eligible for this study. This was the first exam where all the HAI 
components were measured, and we limited our study to participants 60 years 
and older because the HAI was developed in an older population and does not 
show much variability in younger adults. Complete HAI and covariate data were 
available for 934 participants. The Institutional Review Board of Boston 
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University Medical Campus approved all study protocols, and all participants 
provided written informed consent. 
Offspring Exam 5 Data 
At each research examination, participants underwent a physician 
administered medical history interview and physical examination including 
measurement of resting blood pressure, technician-administered questionnaires 
including cognitive function, pulmonary function testing, and laboratory 
measurements. The HAI comprised information from five physiologic systems: 
systolic blood pressure (cardiovascular), fasting glucose (metabolic), creatinine 
(kidney), Mini-Mental State Exam (brain), and forced vital capacity (pulmonary). 
Systolic blood pressure was computed by averaging two physician-obtained 
measurements, while fasting glucose and serum creatinine were collected from 
routine laboratory tests.31 The Mini-Mental State Exam was administered by 
trained interviewers following a standard protocol.32 Forced vital capacity was 
collected according to American Thoracic Society standards using a Collins 
Survey II spirometer (SandM Instruments, Doylestown, PA).33,34 
Healthy Aging Index 
Data values for each component were arranged into three groups; the least 
healthy group was assigned a score of 2, the middle group a score of 1, and the 
healthiest group a score of 0. The component scores were summed to create the 
HAI, ranging from 0 (healthiest) to 10 (unhealthiest). Cutoffs for the three groups 
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were replicated from Sanders et al,2 which used clinical cut-points for glucose, 
tertiles from their samples for systolic blood pressure and Mini-Mental State 
Exam, and sex-specific tertiles for forced vital capacity and serum creatinine 
(Tables 
Table 1). Participants using anti-hypertensives, medication for diabetes, or 
who had previously reported being diagnosed with pulmonary disease (chronic 
obstructive pulmonary disease, emphysema or chronic bronchitis) were assigned 
a score of 2 for that component. 
We investigated the relation of HAI with several other measures previously 
reported to be associated with mortality, including subjective health,35 CRP25,36 
and heart rate.26 Subjective health was self-reported by the participants 
answering the question “In general, how is your health now?” with response 
choices: excellent, good, fair or poor. CRP was obtained at exam five from a 
fasting morning blood sample. Details of the assay for CRP measurements has 
been described, with a correlation coefficient of 0.86 on split specimens.37 
Resting heart rate was obtained from an electrocardiogram at the time of exam 
five by trained technicians. 
 In secondary analyses, three modified healthy aging indices were 
constructed, adding CRP and heart rate, individually and then combined. We 
constructed tertiles based on all exam participants (Tables 
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Table 1). In the community setting, the prevalence of individuals with low 
heart rates of potential clinically significance is very low; the prevalence of 
individuals with heart rates higher than the normal range is higher and has been 
consistently associated with adverse outcomes.26 Thus, higher compared to 
lower heart rate has been consistently associated with greater age-related risk 
across the community, potentially as a marker of abnormal autonomic function as 
well as lower general physical fitness. We scored participants into heart rate 
tertiles assuming that higher heart rate meant greater risk, while considering 
people with heart rates altered by medical intervention still at high risk. 
Participants who had a pacemaker or reported use of cardiac glycosides, calcium 
channel blockers, beta blockers, reserpine derivatives or methyldopa were 
assigned a score of 2 for heart rate. We added these components to the original 
HAI, which ranged from 0 (healthiest) to 12 (unhealthiest) when adding in CRP or 
heart rate individually, or 0 to 14 when including both CRP and heart rate. 
Covariates 
Covariates include body mass index, smoking status, physical activity index 
(PAI), hypertension, diabetes, prevalent CVD (in all-cause mortality and cancer 
models), kidney disease, and pulmonary disease. Cupples et al. provide a 
detailed description of how risk factors were measured.38 Body mass index (BMI) 
was calculated as weight (in kilograms) divided by height (in meters squared). 
Hypertension was defined as a SBP≥140 mmHg, diastolic blood pressure ≥90 
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mmHg or use of anti-hypertensive medications. Diabetes was defined as fasting 
glucose≥126 mg/dL, or use of insulin or oral hypoglycemic medications (1 
participant with non-fasting glucose≥200 mg/dL was also coded as having 
diabetes). PAI and current smoking status were obtained via self-report. PAI was 
calculated as a weighted sum of time within a 24-hour day spent sleeping and 
performing sedentary, slight, moderate, or heavy activities. Participants were 
considered current smokers if they had smoked at least one cigarette per day 
within the past year. Prevalent kidney disease was defined as having an 
estimated glomerular filtration rate <60 mL/min per 1.73m2, and prevalent 
pulmonary disease was a clinical diagnostic impression of emphysema, chronic 
bronchitis or asthma by the examining physician. 
Outcomes: Mortality, CVD and Cancer 
The FHS follows all participants for CVD events and death. A panel of three 
physicians (or a panel of study neurologists for cerebrovascular outcomes) 
adjudicates all suspected CVD events and deaths using data collected from FHS 
examinations, hospitalization records and physician office visit records.39 For this 
study, the three outcomes of interest are all-cause mortality, and incidence of 
cancer or CVD (defined as myocardial infarction, coronary insufficiency, stroke, 
cerebral embolism, death due to CVD). The FHS validates cancer diagnoses with 
pathology reports; 5% of cancer cases in this study were validated based on 
death certificate or clinical diagnosis alone. Follow-up time was limited to the 
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minimum of 10 years, date of event, date of death (in CVD and cancer analyses) 
or date of last contact. 
Statistical Methods 
We summarized continuous variables using means and standard deviations 
(SD), except for CRP, for which we used median and first and third quartiles due 
to the skewed distribution. We used frequency and percent to summarize 
categorical variables. Clinical characteristics were provided for the entire group of 
eligible participants (n=1348), and subsets with complete data (n=934), or 
incomplete data (n=414), with p-values for comparison provided from t-tests 
(continuous), chi-square tests (categorical) or Wilcoxon Rank Sum tests (CRP 
and self-reported health). We analyzed the HAI per unit of index and as a 
categorical variable.1-3 
To assess whether the HAI is predictive of any of the outcomes of interest 
(all-cause mortality or incident CVD or cancer), we used two different Cox 
proportional hazards regression models. The first model adjusts for age, sex and 
behavioral risk factors: physical activity index, current smoking status and BMI. 
The second model also adjusts for co-morbidities: prevalent cancer, 
hypertension, diabetes, CVD, kidney disease and pulmonary disease. C-statistics 
were used as a descriptive method40 to assess model performance and the 
predictive power of HAI over traditional risk factors. We removed participants with 
prevalent CVD or cancer from analyses with respective outcome. 
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We examined the association of prevalent CVD, self-reported health, heart 
rate and CRP with the HAI and its components. We used Spearman correlation 
to see how these measures tracked with HAI, and to ensure that they were not 
highly correlated with the original components. Heart rate and CRP were also 
used as predictors in a series of three Cox regression models, including the two 
models described above, and a model adjusting for age, sex, behavioral risk 
factors and HAI. We created modified indices of HAI by adding in heart rate and 
CRP as additional components. Analyses on the modified HAIs were the same 
as for the original HAI (described above). For the analyses per category of index, 
we kept the HAI groups the same when adding in only one additional component 
(extending the last group to include HAI values of 7-12). However, when we 
added both heart rate and CRP, we created an additional category for HAI values 
11-14. 
Due to missing data in some components (notably forced vital capacity and 
creatinine), we also used multiple imputation by fully conditional specification.13 
Blom’s method of rank normalization was performed on all continuous variables 
prior to imputation.41 All HAI components were multiply imputed using linear 
regression models adjusting for all of the variables in the multivariable Cox model 
including behavioral risk factors and co-morbidities, as well as event indicators 
and cumulative hazards for death and CVD.20 Continuous estimated glomerular 
filtration rate was used in imputation models instead of kidney disease to avoid 
issues with convergence. When possible, the prior exam’s value of the 
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component being imputed was used in the model (i.e., SBP at exam 4 was used 
to impute SBP at exam 5). Additionally, to improve imputation of the two 
components with the most missing values (creatinine and FVC) we used 
covariates known to be correlates of these components: CRP and high-density 
lipoprotein cholesterol were used to impute creatinine; height and weight were 
used to impute FVC.42-44 
Continuous variables were imputed using linear regression models with 
variables listed in Table 2. We imputed hypertension treatment and diabetes 
status using logistic models. We used SAS defaults for multiple imputation, 
imputing variables in order of increasing missing data, creating five imputed 
datasets, with ten burn-in iterations between each. We looked at the association 
of the HAI with mortality and CVD using the imputed data in Cox regression 
models, and we compared results to the analyses run on the observed data. All 
analyses were performed using SAS version 9.3 (SAS Institute, Cary, N.C.). 
Results 
The mean age of the 934 participants with complete HAI and covariate data 
was 66 years, and 51% were female (Table 3). The distribution of HAI was right-
skewed with first and third quartiles of two and four, respectively; 39% of the 
participants fell into the healthiest HAI group with values less than two (Figures 
Figure 1). There were 414 participants with incomplete data: they were older, 
and had a higher prevalence of CVD (12% vs 8%) and kidney disease (21% vs 
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14%), but lower prevalence of pulmonary disease (7% vs 13%) than those with 
complete HAI data. 
Association of HAI with mortality, incident CVD, and cancer 
In the multivariable model adjusting for behavioral risk factors (Model 1), each 
unit of HAI was associated with a 24% higher hazard for death over an average 
follow-up time of 9.33 (SD=1.95) years (Table 4). The HAI also improved 
prediction of mortality, increasing the c-statistic substantially from 0.703 to 0.730 
in Model 1. The hazard ratios (HR) for the categorized HAI showed a similar 
gradient: compared with the reference group (HAI 0-2), the group with HAI 7-10 
had 3.4 fold greater risk of mortality in Model 1 (Table 4). In the multivariable 
model further adjusting for co-morbidities (Model 2) there was a 7% attenuation 
in the HAI effect (HR=1.15, 95% Confidence Interval (CI): 1.00-1.34), and 
including HAI incremented the c-statistic by 0.007. The rates of mortality 
increased across HAI category, as expected (Table 5). 
In the subset of participants without prevalent CVD, association of HAI with 
incident CVD mirrored the results above with a mean (SD) follow-up time of 9.03 
(2.28) years. In Model 1, each unit of HAI was associated with a HR of 1.27 (95% 
CI: 1.13, 1.42) for CVD (Table 6), and showed a substantial increase in the c-
statistic from 0.670 to 0.703. Associations were slightly attenuated in Model 2, 
with a 20% (95% CI: 1.01, 1.42) increase per unit HAI in hazards for CVD and a 
0.011 increase in the c-statistic. In the subset of participants without prevalent 
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cancer, no association of the HAI with incident cancer in this sample of FHS 
participants was observed (Table 7). 
Consideration of additional measures for HAI 
The correlation between HAI and self-reported health was 0.27 (Table 8), and 
the two variables had similar distributions (Figures 
Figure 1). Participants who believed themselves to be in poorer health had 
higher HAI values (Figure 2). 
The Spearman correlations of heart rate, CRP, self-reported health and 
prevalent CVD with the HAI (Table 8) indicated that the HAI tracked with other 
predictors of mortality. The HRs for heart rate and CRP across the series of Cox 
models remained consistent. After adjusting for HAI, the HR for heart rate (per 
1SD difference) was 1.39 (95% CI: 1.20, 1.61), and the HR for CRP (per 1SD of 
log difference) was 1.41 (95% CI: 1.19, 1.67), indicating these markers were 
likely to increase the ability of HAI to predict mortality and CVD (Table 9). Since 
these markers were not highly correlated with the original HAI components 
(Table 8), we created three modified HAI. The HRs per unit of index and per 
category of HAI were consistent across the models predicting mortality using the 
original and modified HAI (Table 4), though the c-statistics were 0.1-0.2 higher 
for the modified versus the original HAI. Including heart rate and CRP in the HAI 
maintains stable HR per unit of index when further adjusting for co-morbidities in 
Model 2 (Table 4), and substantially increased the c-statistic from 0.728 to 0.753 
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(Table 10). Compared to participants in the reference group (HAI 0-2), those with 
a modified HAI between seven and 12 were at a 4-fold increased risk of mortality 
with heart rate included in the HAI, and a 5-fold increased risk of mortality with 
CRP included. With both components included, participants with a modified HAI 
between 11 and 14 were at a 6.6-fold increased risk of mortality. Similar results 
were seen for CVD; however, the group with HAI 11-14 had a 10-fold increase in 
hazards for CVD as compared with the reference group (HAI 0-2) in Model 2 
when using the HAI with both heart rate and CRP included (Table 6). 
Imputation of missing values 
In tertiary analyses, we used fully conditional specification to impute missing 
values for each component of the HAI. By imputing missing values, the sample 
size increased by 44% and the number of deaths by 69%. The results per unit of 
HAI were very similar to those in the complete case analysis, with a 26% 
increase in mortality per unit of HAI in Model 1 (Table 11). The results by HAI 
group were also similar to complete case analysis, but with a steeper gradient in 
HR between the 5-6 and 7-10 groups (Figure 3). Participants with HAI values 
between 7 and 10 had 3.7-fold greater risk of mortality compared with the 
reference group (HAI 0-2). Results per unit of HAI were also similar to the 
complete case analysis for CVD with one anomaly: the HR for the 7-10 group 
was lower due to a small sample size, and of the ten people imputed into this 
group, only one had CVD (Figure 4). 
27 
 
Discussion 
In our community based sample of older adults our main findings are three-
fold. First, the HAI was a strong predictor of mortality and incident CVD, but not 
cancer. Second, incorporation of heart rate and CRP into the HAI reduced the 
attenuation of the association of the HAI with mortality and CVD when adjusting 
for co-morbidities, improved prediction, and better defined the risk in the 
unhealthiest HAI group. Third, multiple imputation methods worked well in this 
setting. 
Previous studies have shown the HAI is associated with mortality, incident 
disability, mobility limitations, slow gait speed and a decline in gait speed.1-3,45 
The ability of HAI to predict mortality and multiple other age-related outcomes 
suggests that it can distinguish between individuals who age well and those who 
do not. Compared with previous studies done on HAI (in CHS1 and Long Life 
Family Study),2 our sample is 10 years younger, on average, and has a more 
balanced gender distribution. The FHS is also not as restrictive as the Health, 
Aging, and Body Composition Study (70-79 years old and high functioning).3 Our 
mortality results mirror those of Newman et al. in the CHS,1 but had a weaker 
association of HAI with mortality than Sanders et al. found in the Health, Aging, 
and Body Composition study3 and CHS.2 We further extend the literature by 
showing the HAI is associated with CVD. 
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Components of the original HAI represent signs of end-organ dysfunction 
rather than any specific process by which dysfunction develops. Biomarkers, 
such as CRP and heart rate, have been proposed as markers of the biological 
aging process that are not specific to a particular organ system, and may be 
more representative of a global aging process. As our data suggest, biomarkers 
appear to add information about the biological aging process that is not 
necessarily represented by functional measures of any particular organ 
system(s). Capturing unhealthy aging processes that are present, even when 
measures of end-organ dysfunction are unchanged or only incrementally altered, 
could provide a more sensitive and potentially clinically useful metric of unhealthy 
aging. 
We used multiple imputation by fully conditional specification to impute 
missing values, increasing sample size. A comparison of those with and without 
HAI supports the assumption that the data are missing at random, with some 
relation between missingness and observed variables: there are statistically 
significant differences for age, prevalent CVD, kidney disease, pulmonary 
disease and Mini-Mental State Exam between those with complete HAI and 
those missing at least one component. Therefore, we believe that the 
assumptions for multiple imputation hold. 
Several limitations of our study merit consideration. FHS is a predominantly 
white population, limiting generalizability to other race/ethnic groups. We also did 
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not have reliable data on all relevant co-morbidities, and pulmonary disease is 
based mainly on self-report. Model 2 adjusts for several co-morbidities that are 
associated with the HAI, and may be over-adjusted. An inadequate number of 
event subtypes precluded analyses of the HAI association with specific causes of 
death. Finally, in some individuals living in the community, very low heart rates 
may yet be associated with increased risk for adverse events, so analyses using 
heart rate as a biomarker of aging should be interpreted with caution. 
Nevertheless, this study has several strengths. We replicated the association 
between HAI and mortality.1,3 extending prior results to a study of all comers who 
are in earlier older age and have a higher percent of females. To our knowledge, 
this is the first use of multiple imputation for the HAI, and it enabled us to 
increase the sample size and number of events. Since missing data is a common 
problem in studies of the aging population, it may benefit other studies. 
 In summary, we found an association between the HAI and mortality in a 
community based study of folks in early older age, as well as an association 
between the HAI and CVD, the leading cause of death among the elderly.46 
Including heart rate and CRP as additional components created a modified HAI 
that has improved prediction of CVD per category of index, indicating that adding 
these to the HAI may be a valuable next step. 
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Tables 
Table 1. Cut-points Used to Group Each Component of the HAI 
Component Gender 
Score for Group 
0 1 2 
SBP, mm Hg  <126 126-143 ≥143 
MMSE, points  ≥27 24-27 <24 
FVC, L 
Men ≥3.84 3.19-3.84 <3.19 
Women ≥2.61 2.14-2.61 <2.14 
Creatinine, mg/dL 
Men <1.1 1.1-1.3 ≥1.3 
Women <0.8 0.8-1.0 ≥1.0 
Glucose, mg/dL  <100 100-125 ≥126 
CRP, mg/dL  ≤0.72 0.72-3.55 ≥3.55 
Heart rate, bpm  ≤60 60-70 ≥70 
SBP=Systolic Blood Pressure; MMSE=Mini-Mental Status Exam; FVC=Forced Vital Capacity; 
CRP=C-reactive Protein; bpm=beats per minute 
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Table 2. Variables Used to Impute Each HAI Component and Covariates 
Variable SBP 
Fasting 
Glucose 
Creatinine FVC MMSE 
Treatment 
for 
Hypertension 
Diabetes 
Age X X X X X X X 
Sex X X X X X X X 
PAI X X X X X   
Smoking Status X X X X X X  
BMI X X X X X X X 
Cancer X X X X X   
Hypertension X X X X X   
Diabetes X X X X X   
eGFR X X X X X   
Pulmonary 
disease 
X X X X X 
  
Incident Death X X X X X   
Cumulative 
hazard for death 
X X X X X 
  
Prevalent or 
Incident CVD 
X X X X X 
  
Cumulative 
hazard for CVD 
X X X X X 
  
Height    X    
Weight    X    
CRP   X     
HDL   X     
SBP at Exam 4 X       
Fasting Glucose 
at Exam 4 
 X    
  
Creatinine at 
Exam 4 
  X   
  
FVC at Exam 3    X    
History of 
Treatment for 
Hypertension 
     
X  
HAI=Healthy Aging Index. SBP=Systolic Blood Pressure. FVC=Forced Vital Capacity. 
MMSE=Mini-Mental State Exam. PAI=Physical Activity Index. BMI=Body Mass Index. 
eGFR=Estimated Glomerular Filtration Rate. CVD=Cardiovascular Disease. CRP=C-reactive 
Protein. HDL=High-density Lipoprotein. 
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Table 3. Sample Characteristics 
 
Total 
Sample 
Complete 
Data  
Incomplete 
Data 
p-value 
Complete 
vs 
Incomplete 
N=1348 N=934 N=414 
Clinical Characteristics     
Age, years (min=60) 65.9±4.5 65.6±4.4 66.6±4.8 0.0001 
Female, N (%) 699 (52) 474 (51) 225 (54) 0.22 
Body mass index, kg/m2 27.7±4.8 27.6±4.7 27.8±4.9 0.63 
Physical activity index 33.8±5.7 33.8±5.6 33.7±6.1 0.80 
Current smoker, N (%) 192 (14) 133 (14) 59 (14) 0.96 
Cancer, N (%) 121 (9) 83 (9) 38 (9) 0.86 
Hypertension, N (%) 721 (54) 489 (52) 232 (57) 0.14 
Treatment for hypertension, N 
(%) 
473 (35) 315 (34) 158 (39) 0.07 
Cardiovascular disease, N (%) 128 (10) 77 (8) 51 (12) 0.02 
Diabetes, N (%) 171 (13) 115 (12) 56 (14) 0.38 
Treatment for diabetes, N (%) 92 (7) 59 (6) 33 (8) 0.26 
Kidney disease, N (%) 177 (15) 131 (14) 46 (21) 0.02 
Pulmonary disease, N (%) 150 (11) 123 (13) 27 (7) 0.0003 
CRP, mg/dL* 2.6 (0.8, 6.8) 2.5 (0.7, 6.6) 3.2 (0.9, 7.4) 0.20 
Heart rate, bpm 66±10 66±12 67±12 0.07 
Self-reported health    0.08 
Excellent 509 (38) 367 (39) 142 (35)  
Good 676 (50) 466 (50) 210 (52)  
Fair 137 (10) 90 (10) 47 (12)  
Poor 17 (1) 10 (1) 7 (2)  
HAI Components     
Systolic blood pressure, mm Hg 134±20 134±19 
134±20 
(N=413) 
0.85 
Fasting glucose, mg/dL 108±35 107±33 
110±39 
(N=379) 
0.09 
Creatinine, mg/dL 0.92±0.90 0.92±0.31 
0.95±0.36 
(N=225) 
0.28 
Forced vital capacity, L 3.47±0.85 3.48±0.86 
3.43±0.82 
(N=180) 
0.46 
Mini-mental status exam 28.4±1.8 28.5±1.7 
28.2±2.0 
(N=405) 
0.004 
HAI 3.1±1.8 3.1±1.8 -- -- 
HAI=Healthy Aging Index, CRP=C-reactive protein 
Values are shown as means±standard deviation or percentages. 
*CRP values are shown as median (25th, 75th percentiles). 
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Table 4. Associations of Modified HAI with All-Cause Mortality 
Outcome Events/N 
HR (95% CI) 
Model 1 
HR (95% CI) 
Model 2 
Original HAI    
HR per unit of index 138/934 1.24 (1.13,1.36) 1.15 (1.00,1.34) 
HR per category of index    
 0-2 28/364 1.00 1.00 
 3-4 55/368 1.69 (1.06,2.68) 1.48 (0.89,2.48) 
 5-6 42/166 2.99 (1.81,4.92) 2.23 (1.13,4.40) 
 7-10 13/36 3.41 (1.70,6.83) 2.29 (0.89,5.88) 
    
HAI Including Heart Rate    
HR per unit of index 132/914 1.24 (1.15,1.35) 1.22 (1.08,1.37) 
HR per category of index    
 0-2 12/193 1.00 1.00 
 3-4 23/277 1.30 (0.64,2.62) 1.24 (0.60,2.53) 
 5-6 52/271 2.88 (1.53,5.46) 2.62 (1.30,5.29) 
 7-12 45/173 3.95 (2.05,7.62) 3.03 (1.30,7.05) 
  -- -- 
HAI Including CRP    
HR per unit of index 132/914 1.25 (1.15,1.36) 1.21 (1.07,1.36) 
HR per category of index    
 0-2 11/202 1.00 1.00 
 3-4 35/314 1.88 (0.96,3.72) 1.67 (0.83,3.37) 
 5-6 44/247 2.81 (1.43,5.51) 2.37 (1.13,4.95) 
 7-12 42/151 4.88 (2.45,9.74) 3.59 (1.53,8.42) 
  -- -- 
HAI Including Heart Rate and CRP    
HR per unit of index 132/914 1.24 (1.16,1.34) 1.24 (1.12,1.37) 
HR per category of index    
 0-2 7/115 1.00 1.00 
 3-4 9/203 0.72 (0.27,1.95) 0.64 (0.24,1.75) 
 5-6 39/261 2.48 (1.10,5.57) 2.36 (1.02,5.45) 
 7-10 67/310 3.51 (1.58,7.79) 2.95 (1.21,7.18) 
 11-14 10/25 6.57 (2.43,17.81) 
4.88 
(1.42,16.80) 
HAI=Healthy Aging Index, HR=Hazard Ratio 
Model 1 is adjusted for age, sex, physical activity index, smoking status, and body mass index. 
Model 2 is adjusted for the covariates in Model 1 and baseline cancer, hypertension, CVD, 
diabetes, kidney disease and pulmonary disease
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Table 5. Numbers of Events and Sample Size per Category of HAI 
 Original Including Heart Rate Including CRP 
Including CRP and 
Heart Rate 
Outcome Events/N 
Rate per 
1000 pyrs 
Events/N 
Rate per 
1000 pyrs 
Events/N 
Rate per 
1000 pyrs 
Events/N 
Rate per 
1000 pyrs 
All-Cause Mortality         
Per unit of index 138/934 -- 132/914 -- 132/914 -- 132/914 -- 
Per category of index         
0-2 28/364 7.9 12/193 6.4 11/202 5.6 7/115 6.2 
3-4 55/368 16.0 23/277 8.6 35/314 11.7 9/203 4.5 
5-6 42/166 28.8 52/271 21.1 44/247 19.4 39/261 15.9 
7-10* 13/36 43.8 45/173 29.8 42/151 32.1 67/310 24.0 
11-14 -- -- -- -- -- -- 10/25 52.7 
         
CVD         
Per unit of index 103/857  103/839 -- 103/839 -- 103/839 -- 
Per category of index         
0-2 24/349 7.3 12/188 6.7 6/197 3.2 4/112 3.7 
3-4 43/340 14.0 21/264 8.5 36/294 13.5 13/196 7.0 
5-6 29/143 24.5 39/246 18.1 33/227 16.3 33/244 15.1 
7-10* 7/25 35.1 31/141 26.6 28/121 28.6 48/272 20.4 
11-14 -- -- -- -- -- -- 5/15 46.1 
CVD = Cardiovascular disease, CRP = C-reactive protein, pyrs=person years 
*The last HAI group is 7-10 for the original HAI, and 7-12 for the HAI including heart rate or CRP individually.
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Table 6. Associations of Modified HAI with CVD 
Outcome Events/N 
HR (95% CI) 
Model 1 
HR (95% CI) 
Model 2 
Original HAI    
HR per unit of index 103/857 1.27 (1.13,1.42) 1.20 (1.01,1.42) 
HR per category of index    
 0-2 24/349 1.00 1.00 
 3-4 43/340 1.62 (0.97,2.70) 1.41 (0.79,2.53) 
 5-6 29/143 2.79 (1.58,4.91) 1.98 (0.90,4.36) 
 7-10 7/25 3.31 (1.38,7.93) 2.47 (0.84,7.25) 
    
HAI Including Heart 
Rate 
 
 
 
HR per unit of index 103/839 1.25 (1.14,1.38) 1.23 (1.07,1.41) 
HR per category of index    
 0-2 12/188 1.00 1.00 
 3-4 21/264 1.16 (0.57,2.38) 1.10 (0.52,2.32) 
 5-6 39/246 2.33 (1.20,4.51) 1.98 (0.93,4.24) 
 7-12 31/141 3.24 (1.62,6.49) 2.31 (0.90,5.93) 
    
HAI Including CRP    
HR per unit of index 103/839 1.26 (1.14,1.39) 1.23 (1.08,1.41) 
HR per category of index    
 0-2 6/197 1.00 1.00 
 3-4 36/294 3.72 (1.56,8.85) 3.54 (1.46,8.62) 
 5-6 33/227 4.03 (1.66,9.76) 3.49 (1.35,9.07) 
 7-12 28/121 7.78 (3.14,19.26) 6.32 (2.20,18.19) 
    
HAI Including Heart 
Rate and CRP 
 
 
 
HR per unit of index 103/839 1.24 (1.14,1.35) 1.23 (1.10,1.39) 
HR per category of index    
 0-2 4/112 1.00 1.00 
 3-4 13/196 1.85 (0.60,5.69) 1.81 (0.58,5.61) 
 5-6 33/244 3.80 (1.34,10.79) 3.52 (1.20,10.32) 
 7-10 48/272 4.94 (1.75,13.94) 3.82 (1.22,11.95) 
 11-14 5/15 9.42 (2.44,36.38) 10.04 (2.18,46.36) 
HAI=Healthy Aging Index, CVD=Cardiovascular disease, HR=Hazard Ratio 
Model 1 is adjusted for age, sex, physical activity index, smoking status, and body mass index. 
Model 2 is adjusted for the covariates in Model 1 and baseline cancer, hypertension, diabetes, 
kidney disease and pulmonary disease. 
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Table 7. Association between HAI and Cancer 
Outcome Events/N 
HR (95% CI) 
Model 1 
HR (95% CI) 
Model 2 
Cancer    
HR per unit of index 138/851 1.01 (0.91,1.11) 0.93 (0.79,1.08) 
HR per category of 
index 
 
 
 
 0-2 52/336 1.00 1.00 
 3-4 56/340 1.04 (0.71,1.53) 0.93 (0.60,1.45) 
 5-6 26/149 1.22 (0.75,1.99) 1.01 (0.51,1.99) 
 7-10 4/26 1.00 (0.36,2.81) 0.84 (0.25,2.83) 
HAI=Healthy Aging Index, HR=Hazard Ratio 
Model 1 is adjusted for age, sex, physical activity index, smoking status, and body mass index. 
Model 2 is adjusted for the covariates in Model 1 and baseline cancer, hypertension, CVD, 
diabetes, kidney disease and pulmonary disease.  
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Table 8. Spearman Correlations of HAI Components with Other Markers of Aging 
 
Healthy Aging 
Index 
Systolic blood 
pressure 
Fasting 
glucose 
Creatinine 
Forced Vital 
Capacity 
Mini-Mental 
Status Exam 
Heart rate 
0.13 
P=0.0001 
N=955 
0.07 
P=0.02 
N=1347 
0.10 
P=0.0002 
N=1312 
-0.14 
P<.0001 
N=1158 
-0.23 
P<.0001 
N=1068 
-0.03 
P=0.25 
N=1337 
CRP 
0.28 
P<.0001 
N=934 
0.15 
P<.0001 
N=1289 
0.18 
P<.0001 
N=1276 
-0.02 
P=0.40 
N=1135 
-0.22 
P<.0001 
N=1037 
-0.06 
P=0.03 
N=1285 
Self-reported 
health 
0.27 
P<.0001 
N=954 
0.10 
P=0.0004 
N=1339 
0.10 
P=0.0002 
N=1306 
-0.02 
P=0.47 
N=1153 
-0.16 
P<.0001 
N=1066 
-0.12 
P<.0001 
N=1337 
Prevalent CVD 
0.16 
P<.0001 
N=955 
-0.009 
P=0.75 
N=1347 
0.13 
P<.0001 
N=1313 
0.12 
P<.0001 
N=1159 
-0.004 
P=0.89 
N=1069 
-0.10 
P=0.0002 
N=1339 
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Table 9. Associations of Other Markers of Aging with Mortality and CVD in 
Sample with Complete HAI Data 
Marker 
HR (95% CI) 
Model 1: 
Behavioral Risk 
Factors 
Model 2: 
+ Prevalent Disease 
Model 3: 
Model 1 + HAI 
All-Cause Mortality    
Heart rate, per 1-SD 1.44 (1.24,1.68) 1.36 (1.16,1.58) 1.39 (1.20,1.61) 
CRP, per 1-SD of log 1.49 (1.26,1.76) 1.45 (1.22,1.73) 1.41 (1.19,1.67) 
    
CVD    
Heart rate, per 1-SD  1.38 (1.14,1.67) 1.28 (1.06,1.56) 1.30 (1.07,1.58) 
CRP, per 1-SD of log  1.31 (1.07,1.59) 1.28 (1.05,1.57) 1.22 (1.00,1.50) 
There were 138 deaths (of n=934) over an average follow-up time of 9.33±1.95 years 
There were 103 CVD events (of n=857,excluding participants with prevalent CVD) over an 
average follow-up time of 9.03±2.28 years 
Model 1 is adjusted for age, sex, physical activity index, smoking status, and body mass index. 
Model 2 is adjusted for the covariates in Model 2 in addition to baseline cancer, hypertension, 
CVD [in all-cause mortality models], diabetes, kidney disease and pulmonary disease. 
Model 3 is adjusted for the covariates in Model 1 and HAI 
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Table 10. C-Statistics for Models Including Original and Modified HAI 
Outcome Model 1 Model 2 
All-Cause Mortality 
Without 
HAI 
Original 
HAI 
HAI 
with 
CRP 
HAI 
with HR 
HAI with 
CRP and 
HR 
Without 
HAI 
Original 
HAI 
HAI with 
CRP 
HAI 
with HR 
HAI with 
CRP 
and HR 
Per unit of index 0.696 0.724 0.734 0.737 0.744 0.728 0.737 0.745 0.747 0.753 
Per category of index 0.696 0.725 0.731 0.736 0.748 0.728 0.738 0.742 0.746 0.757 
           
CVDa           
Per unit of index 0.674 0.707 0.717 0.715 0.723 0.711 0.722 0.731 0.728 0.736 
Per category of index 0.674 0.706 0.718 0.713 0.721 0.711 0.720 0.734 0.725 0.732 
All analyses performed on subset of participants with complete HAI, covariate, and CRP data (n=914 for all-cause mortality models, n=839 
for CVD models)  
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Table 11. Associations in Imputed Data Between HAI and All-Cause-
Mortality and CVD 
Outcome Events/Na 
HR (95% CI) 
Model 1 
HR (95% CI) 
Model 2 
All-Cause Mortality    
HR per unit of index 233/1348 1.26 (1.17,1.36) 1.20 (1.07,1.35) 
HR per category of index    
 0-2 51/523 1.00 1.00 
 3-4 86/526 1.50 (1.03,2.19) 1.39 (0.91,2.13) 
 5-6 72/246 2.70 (1.84,3.96) 2.27 (1.35,3.82) 
 7-10 24/53 3.66 (2.07,6.45) 2.62 (1.18,5.82) 
    
CVDb    
HR per unit of index 153/1220 1.29 (1.17,1.43) 1.14 (0.99,1.33) 
HR per category of index    
 0-2 33/498 1.00 1.00 
 3-4 64/480 1.85 (1.19,2.87) 1.49 (0.91,2.44) 
 5-6 48/207 3.52 (2.08,5.95) 2.06 (0.98,4.33) 
 7-10 8/35 3.02 (1.26,7.23) 1.68 (0.63,4.47) 
HAI=Healthy Aging Index, CVD=Cardiovascular disease, HR=Hazard ratio 
Model 1 is adjusted for age, sex, physical activity index, smoking status, and body mass index. 
Model 2 is adjusted for the covariates in Model 1 and baseline cancer, hypertension, CVD [in all-
cause mortality models], diabetes, kidney disease and pulmonary disease. 
aMean # events/N per imputation. 
bCVD models exclude participants with prevalent CVD. 
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Figures 
Figure 1. Histograms of Healthy Aging Index and Self-Reported Health at 
Exam 5 (n=934) 
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Figure 2. Side-by-side Boxplots of HAI by Self-Reported Health 
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Figure 3. Hazard Ratio for All-Cause Mortality by HAI Group in Multivariable 
Models Comparing Observed vs Imputed 
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Figure 4. Hazard Ratio for CVD by HAI Group in Multivariable Models 
Comparing Observed vs Imputed 
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CHAPTER 3 – MEANS, CORRELATIONS AND SLOPES 
Introduction 
Motivation 
Based on prior literature for missing data methods for score variables,17,18 I 
use variations of fully conditional specification (FCS) to impute missing values for 
the individual components of the healthy aging index (HAI), and then reconstruct 
the HAI in the m multiply imputed data sets. However, to my knowledge, there is 
little known about how the imputation methods maintain the mean, correlation 
and slope of the reconstructed score variables with longitudinal measurements. 
Overview 
In this chapter, I describe the methods and results of my simulation study to 
evaluate and compare four methods of multiple imputation (MI) for the analysis of 
means, correlations and slope of a score variable measured repeatedly over 
time. The methods section begins by describing how the data are simulated, then 
introduces the masking mechanisms used to create missing values. I then 
introduce the four methods of MI, the statistical analyses I perform on the 
imputed data, and the metrics I use to evaluate and compare the imputation 
methods. In the results section, I evaluate and compare the imputation methods 
to complete case (CC) analysis using the metrics previously described. Finally, I 
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discuss the strengths and limitations of my study, and make recommendations 
on which imputation methods to use in similar situations. 
Methods 
Simulation 
I simulated a complete data set of n=1,000,000 observations based on the 
motivating HAI project in the Framingham Heart Study (FHS). Recall, there are 
five components of the HAI: systolic blood pressure (SBP), Mini-Mental State 
Exam (MMSE), forced vital capacity (FVC), glucose and creatinine. I used 
information on the correlation of the components of the HAI at each exam and 
age at baseline from participants with available data to design the simulated 
data. For example, I mimicked the correlation structure observed in FHS among 
components and across examinations. The FVC values are very strongly 
correlated (r=0.91-0.97) across exams, and the other components have 
moderate (i.e. r=0.45 for MMSE) to high (i.e. 0.70 for glucose) correlations across 
exams. I simulated MMSE to have a constant correlation structure (r=0.45 across 
all exams), and I simulated the other components to have varying degrees of an 
autoregressive correlation structure. For between component correlation, FVC 
and creatinine have a moderate (r=0.15-0.25) correlation, decreasing across 
exams, while the other components were simulated with zero to low (r=±0.1) 
pairwise correlation within exam. Baseline age is weakly (r=0.06 for glucose) to 
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moderately (r=-0.35 for MMSE) correlated with each of the components at each 
time point. For the full list of target correlations, see Table 12. 
I generated a random uniform variable, and I set individuals with values ≤0.48 
to be male. Once age and the HAI components were simulated as standard 
normal variables based on the correlation structure, I calibrated them to have 
similar means and standard deviations (SD) as the FHS data. I simulated SBP, 
MMSE and creatinine to have a constant mean and SD across the four exams, 
whereas I forced a decreasing mean FVC across exams and an increasing mean 
glucose across exams. Males were assigned higher mean age, FVC, glucose 
and creatinine levels, lower mean MMSE levels, and the same mean SBP levels 
as females. See Table 13 for the full list of means and SDs used. Finally, I 
calculated the HAI at each exam using the same thresholds that were used in 
FHS4 (Table 14). 
Masking 
It is likely that multiple mechanisms account for missing data in the FHS 
Offspring cohort. A comparison of participants with and without HAI at baseline 
supports the assumption that some of the data are at least missing at random 
(MAR), with some relation between missingness and observed variables: there 
are statistically significant differences for age, prevalent cardiovascular disease 
(CVD), kidney disease, pulmonary disease and MMSE between those with 
complete HAI and those missing at least one component. FVC is a grueling 
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procedure that involves forcefully exhaling all of the air in the lungs into a tube 
repeatedly. This part of the examination is often refused, especially by older 
participants, or those with breathing difficulty, making it the component with the 
most missing data, and likely missing not at random (MNAR). 
I created three versions of masked data sets from the simulated complete 
data set using missing completely at random (MCAR), MAR and MNAR 
mechanisms (by applying a single mechanism to each data set). I used FHS data 
as a guide to the percent of data that were missing, both due to non-attendance 
and for missing components for exam attendees (Table 15). To mask data 
MCAR, I randomly assigned a missing data indicator for each component and 
overall attendance using a Bernoulli(𝑝𝑐,𝑡) distribution, where 𝑝𝑐,𝑡 was the percent 
of data I wanted to mask for that component at that exam (Table 15). 
For the MAR data, I used the value of HAI at the previous exam to predict 
non-attendance at the current exam, and I used the value of each component at 
the previous exam to predict missingness of that component at the current exam. 
I ran logistic models in the FHS data predicting if a component is missing at the 
next exam from the value of the component at the current exam. I used the 
coefficients from the logistic models in the FHS data to estimate the parameters 
used to generate predicted probabilities (pp) of missingness in the simulated 
data. I randomly assigned missing data indicators from a Bernoulli(pp) 
distribution for each component at each exam, as well as an overall non-
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attendance indicator. Glucose and creatinine were masked simultaneously, so if 
one of them was missing, the other was also missing (this follows the assumption 
that both items were missing due to a lack of blood draw). 
Finally, data were masked MNAR for non-attendance and the FVC 
component: participants with higher HAI were more likely to be non-attendees 
and participants with lower FVC were more likely to be missing the FVC 
component. More specifically, I divided the data into quartiles, and randomly 
masked the two worst groups, with a higher percentage masked in the worst 
quartile. For example, for FVC, I masked 40% of the data in the first quartile, and 
20% of the data in the second quartile for an overall missing rate of 15% at exam 
5. The remainder of the components were masked MAR within the MNAR data 
set. 
Imputation Methods 
I compared the statistical performance of four methods of imputation: 
1. Cross-sectional fully conditional specification (XFCS) 
2. Longitudinal FCS (LFCS) 
3. All FCS (AFCS) 
4. Two-fold FCS (2fFCS) 
At each exam, XFCS used other HAI components at that exam to impute the 
missing HAI component at that exam using FCS. For example, to impute SBP at 
50 
 
exam 5, I used FVC, MMSE, creatinine and glucose, all from exam 5, in the 
imputation model. LFCS used the same HAI component at other exams to 
impute each component at each exam. For example, to impute SBP at exam 5, I 
used SBP at exams 6, 7 and 8 but no other components of HAI at any exam. 
AFCS used all other variables at all time points to impute each component at 
each exam. For example, to impute SBP at exam 5, I used SBP at exams 6-8, 
and FVC, MMSE, creatinine and glucose at exams 5-8. Finally, 2fFCS used all 
other variables at the current and adjacent time points in a two-stage procedure. 
For example, to impute SBP at exam 6, I used SBP at exams 5 and 7, and FVC, 
MMSE, creatinine and glucose at exams 5-7. For the first and last exam, 2fFCS 
incorporated the information from the single adjacent exam (i.e. only data from 
exam 5 and 6 were used to impute values at exam 5, and only data from exam 7 
and 8 were used to impute values at exam 8). Due to the convergence issues 
Welch et al reported, I monitored convergence failure rates for all of the 
imputation methods, especially AFCS.16 
Statistical Analyses 
In my thesis, I explored how different types of missing data influenced the 
effectiveness of each of the imputation methods in different types of statistical 
analyses. In this chapter, I focused on the effect of missing data and the 
corresponding simulation method on the analyses of means, correlations and 
slope of the HAI across exams. My aim was to determine the best imputation 
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method to use to preserve the true correlation across the exams, while 
minimizing the bias in the estimates of the means and minimizing the variance of 
the estimate of the means and correlations. For the slope of the HAI across 
exams, I used linear mixed effects (LME) models to analyze the trend of the HAI 
and its components across exams, as well as the ability of the imputation 
methods to maintain this trend. 
Means 
At each time point, I calculated the mean HAI value by averaging the HAI 
across the individual observations within each of the simulated datasets. 
Correlations 
I was interested in the entire correlation matrix of pairwise HAI values across 
each of the exams, calculated among individual observations within each of the 
simulated datasets. Due to the asymmetric distribution of the correlation 
coefficient, ρ, Fisher’s z-transformation was applied to all correlation coefficients 
prior to pooling the estimates.17 
Slopes 
To see how the HAI changes over time, I used LME models to estimate the 
slope of the HAI across exams. I used a random intercepts model with a 
compound symmetry covariance structure to model the correlated errors among 
repeated observations on the same subject. 
52 
 
Metrics of Evaluation 
To evaluate the performance of the different imputation methods, I used four 
standard measures of assessing the ability of the imputation method to recover 
missing data: bias (or percent bias), width of the confidence interval (CI), 
coverage probability and relative efficiency. Define the parameter of interest as 𝜃, 
and the parameter estimate from the sample as 𝜃. Bias is defined as the 
difference between the expected value of the estimate and the population 
parameter, or 𝐸(𝜃) − 𝜃, and percent bias is the bias divided by the population 
parameter, or 
𝐸(?̂?)−𝜃
𝜃
. 
I calculated the width of the CI as the upper limit minus the lower limit, with 
smaller widths indicating better precision. The coverage probability is the 
probability that the CI for an estimator contains the true parameter. Both CI width 
and coverage probability are dependent on the type I error rate, α. I used α=0.05 
and 95% CIs for both of these metrics. 
Recall 𝑚 is defined as the number of imputed datasets, the point estimate in 
dataset i is 𝜃𝑖, and the combined point estimate is the average across all imputed 
datasets: ?̅? =
1
𝑚
∑ 𝜃𝑖
𝑚
𝑖=1 . If the variance estimate in dataset i is ?̂?𝑖, then the within-
imputation variance is the average of the variance estimates of the 𝑚 complete 
datasets: ?̅? =
1
𝑚
∑ ?̂?𝑖
𝑚
𝑖=1 . The between-imputation variance is 𝐵 =
1
𝑚−1
∑ (𝜃𝑖 −
𝑚
𝑖=1
?̅?)
2
. Then the relative increase in variance is defined by 𝜏 =
(1+𝑚−1)𝐵
?̅?
. If 𝑣𝑚 is 
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defined as the degrees of freedom for the distribution of the t statistic 
corresponding to the ratio of the point estimate 𝜃 divided by the estimate of the 
standard error, and 𝛾 =
𝜏+2/(𝑣𝑚+3)
𝜏+1
 is defined as the fraction of missing 
information, then the relative efficiency is calculated as 𝑅𝐸 = (1 +
𝛾
𝑚
)
−1
.47,48 
Convergence 
I monitored convergence of the iterations between imputed datasets to 
ensure that the imputed values were not dependent on the starting value and that 
they were being pulled from a stationary distribution. I used the potential scale 
reduction factor (PSRF) method originally developed by Gelman and Rubin,49 
and modified by Brooks and Gelman.50 Let 𝑘 be the number of iterations run 
between imputed datasets (after discarding 𝑘 burn-in iterations), and let 𝜓 be a 
random variable with mean 𝜇 and variance 𝜎2. The 𝑢th of the 𝑘 iterations of 𝜓 in 
chain 𝑗 (of 𝑚 imputed datasets) is denoted 𝜓𝑗𝑢. The between-sequence variance 
is 
𝐵
𝑘
=
1
𝑚−1
∑ (𝜓𝑗.̅̅ ̅̅ − 𝜓..̅̅ ̅)
2𝑚
𝑗=1 , and the within-sequence variance is 𝑊 =
1
𝑚(𝑘−1)
∑ ∑ (𝜓𝑗𝑢 − 𝜓𝑗.̅̅ ̅̅ )
2𝑘
𝑢=1
𝑚
𝑗=1 . The variance is estimated by ?̂?+
2 =
𝑘−1
𝑘
𝑊 +
𝐵
𝑘
. Under 
certain conditions, this estimate is unbiased. However, accounting for sampling 
variability, the pooled posterior variance is estimated by ?̂? = ?̂?+
2 +
𝐵
𝑚𝑘
. The original 
PSRF was estimated by ?̂? =
𝑉
𝑊
, and the modified PSRF is estimated by ?̂?𝑐 =
𝑑+3
𝑑+1
?̂?, where 𝑑 is the estimated degrees of freedom for a Student-t approximation 
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to the posterior inference. Here, the PSRF is estimated by ?̂?𝑐, and it is a function 
of the between and within sequence variances. If ?̂?𝑐 is close to 1, convergence is 
achieved. I used the cutoff value of 1.2 to monitor convergence in my simulations 
using the default 10 iterations, and compared to 50 and 100 iterations.51 
Results 
Means (Table 16), correlations (Table 17), and percent missing values (Table 
18) of HAI across exams in the simulated data set of n=1,000,000 are shown 
below. The means and correlations served as my true parameters when 
calculating bias for estimates from masked and imputed data sets, and the 
percent of missing values was in line with what I expected for each missing data 
mechanism (Table 15). 
Assessment of Means 
Figure 5-Figure 8 displays the mean HAI for each scenario. Each figure 
shows the mean of HAI at each exam in different panels. Within each panel, 
there are three groups of boxplots representing the three different missing data 
mechanisms, and within each group, there are four boxplots for the different 
imputation methods. The gray line shows the mean HAI in the full set of 
unmasked data (n=1,000,000). The green, blue and red dashed lines represent 
the CC estimate of the mean in the MCAR, MAR and MNAR data sets, 
respectively. There are four different figures for each combination of sample size 
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(n) and number of imputed data sets (m) for each measure: mean, confidence 
interval (CI) width, and relative efficiency (RE). 
The mean HAI increased across exams, as was intended with the setup of 
the simulations to mimic aging: as people age, they tend to be less healthy, and 
higher HAI values represent less healthy individuals (Figure 5). All reported 
estimates are percent bias (or absolute value of percent bias, since all imputation 
methods underestimate the mean). I considered less than 5% bias as relatively 
unbiased, 5-10% as moderately biased, and more than 10% as biased. Focusing 
on the MCAR results, CC analyses and all four imputation methods performed 
similarly and were able to recover data with unbiased estimates (0%) at exam 5, 
when the percent of missing values was lowest (24%). As the percent of missing 
values increased across exams (up to 56%), all of the imputation methods and 
the CC analyses had similar, unbiased (<0.1%) estimates of the mean HAI. 
When the data were masked MAR, all of the imputation methods produced 
relatively unbiased estimates of the mean (<4.8%) at all exams, consistent with 
the CC analysis, although XFCS had greater bias than the longitudinal methods. 
When the data were MNAR, all of the imputation methods underestimated the 
mean HAI (0.7%-20%). All of the methods were relatively unbiased at exam 5 
(<1.7%) and at exam 6 (<3.9%), except for XFCS which was moderately biased 
(8.2%). The longitudinal methods produced moderately biased estimates at exam 
7 (7.0-7.3%) and biased estimates at exam 8 (10.5-11.2%), while XFCS had 
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biased estimates at both of the later exams (up to 20%). In general, XFCS failed 
to improve on the CC analysis, while AFCS, LFCS and 2fFCS performed 
similarly and better than CC analysis. However, the longitudinal methods still 
produce moderately biased to biased means as the percent of missing data 
increases. 
Results were very similar when increasing from five to 20 imputations (Figure 
6). Similar patterns were seen when n=100, though the variability increased due 
to the smaller sample size, leading to a larger scale on the figures for n=100 vs 
n=1000 (Figure 7-Figure 8). 
The next group of figures shows the CI width for the mean HAI at each exam 
(Figure 9-Figure 12). The figures have the same layout described previously. The 
MCAR results for n=1000 and m=5 showed that the median and spread of the CI 
width increased as the percent of missing data increased across exams (Figure 
9). XFCS had slightly wider CIs (0.22-0.29) than the three longitudinal methods 
(0.21-0.25). The results for MAR and MNAR were similar to MCAR, with the 
exception that XFCS had narrower CIs for MNAR (0.25) than for MCAR (0.28) 
and MAR (0.27), most notably at exam 8. This was likely a feature of masking 
higher HAI values in the MNAR data set, which limited the distribution of 
plausible values for the imputations. 
Increasing from m=5 to m=20 reduced the spread of the CI width (Figure 10). 
Otherwise, the results for m=20 were very similar to m=5, except all of the 
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imputation methods showed slightly smaller CI width for MNAR than for other 
missing data mechanisms. As expected, the CI width was much larger and more 
variable for the samples of n=100 due to the smaller sample size. Otherwise, the 
same patterns persist in Figure 11 and Figure 12 as did in the figures for n=1000. 
The coverage probabilities for the CIs of the mean HAI across exams are 
shown in Figure 13-Figure 16. The layout of these figures are similar to the 
figures for mean and CI width, with point estimates shown instead of boxplots. I 
also introduced a new symbol, a black square, which represents the CC 
estimate. For n=1000 and m=5 and data MCAR, the coverage probabilities were 
consistently high across exams (>0.95), even with the increase in percent of 
missing values (Figure 13). When the data were MAR, the coverage probabilities 
remained high across the exams for the three longitudinal imputation methods, 
but the XFCS method showed a decline as the percent of missing data 
increased. The coverage probability for the CC analyses consistently fell 
between XFCS and the longitudinal methods. For MNAR, the coverage 
probabilities were about 0.93 for the three longitudinal methods at exam 5, 0.89 
for CC, and slightly lower at 0.82 for XFCS. As the percent of missing data 
increased, all of the imputation methods had a decrease in coverage probability, 
with zero coverage for all methods at exams 7 and 8. 
Increasing from 5 to 20 imputations had little effect on the estimates of 
coverage probability (Figure 14). The coverage probabilities were less affected 
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by the increase in missing data when the sample size was smaller, likely due to 
the larger CI widths (n=100,Figure 15). When the data were MCAR or MAR, all of 
the imputation methods and CC analysis had coverage probabilities above 0.93, 
with the exception of CC at exam 7 (0.88) and XFCS at exam 8 (0.89) when data 
was MAR. For MNAR, XFCS showed the most rapid decline in coverage 
probability, while the longitudinal methods had a more gradual decline. AFCS 
had slightly higher values than the other longitudinal methods at later exams, and 
CC analysis had slightly better coverage probabilities than XFCS. 
The distribution of RE was very skewed, and showed smaller values and 
increased variability as the percent of missing data increased across exams 
(Figure 17-Figure 20). When the data were MCAR, the three longitudinal 
methods (AFCS, LFCS, 2fFCS) performed similarly (RE>0.95), and better than 
XFCS (RE>0.92). When data were MAR and MNAR, the longitudinal methods 
still out performed XFCS, though 2fFCS had slightly lower (by 0.002) RE than the 
other longitudinal methods at exams 7 and 8. 
Increasing from m=5 to m=20 yielded much higher RE, so the y-axis ranges 
from 0.97 to 1 (Figure 18). The results were similar as in m=5. 2fFCS had a 
slightly lower RE as compared to the other longitudinal methods at exam 8 with 
MAR, in addition to MNAR. When the sample size was lowered to n=100, the 
patterns were the same as for the larger sample size. There was one exception: 
LFCS seemed to have slightly higher RE than AFCS and 2fFCS, especially when 
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m=20 (Figure 19-Figure 20). The improvement in using m=20 vs m=5 appeared 
to increase as the amount of missing data increased (Figure 21). The results 
were similar for all three missing data mechanisms. The average RE improved 
and the spread of the CI width shrunk by increasing from 5 to 20 imputed data 
sets. 
Assessment of Correlations 
As above, there are four different figures for each combination of n and m for 
each measure (correlation, CI width, and RE). Finally, for each measure, there 
were two versions of the figure for n=1000 and m=5. The first showed all of the 
panels in a single figure, while the second looked at the two rows of panels in 
separate figures to lengthen the panels, allowing a more detailed look at the 
results. 
The correlation matrix of HAI across exams showed the strongest correlations 
at adjacent exams and weaker correlations as the amount of time between 
exams increased. The weakest correlation was between exams 5 and 8 (Figure 
22-Figure 23). Each figure shows the correlation of HAI between the six pairs of 
exams in different panels. The layout within each panel is the same as for the 
figures described above for the means. The gray line in each panel shows the 
correlation in the full set of unmasked data (n=1,000,000). 
In all of the panels within Figure 22-Figure 23, XFCS consistently 
underestimated the correlation (21-60% bias), which was expected since this 
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imputation method did not use information from other exams. Focusing on the 
MCAR mechanism, the three longitudinal imputation methods all performed 
similarly, producing unbiased (≤2% difference) estimates, with the exception of 
2fFCS at non-adjacent exams (up to 6% bias). Again, this was expected due to 
the default settings for 2fFCS only using information from adjacent exams. I re-
ran 2fFCS, increasing the time window to include information from two exams 
and saw improvement, with unbiased estimates of correlation between exams 5 
and 7 and 6 and 8, and only 2% bias between exams 5 and 8 with data missing 
due to MCAR (Figure 27). 
Results for the MAR mechanism were identical to MCAR, whereas the 
estimates under MNAR all showed some bias, with AFCS and LFCS having the 
least (≤4% bias), 2fFCS showed slightly more bias (≤10%) and XFCS had 
extreme bias (≤60%). The same patterns were seen regardless of sample size 
(n=1000 vs n=100) and number of imputed data sets (m=5 vs m=20) (Figure 24-
Figure 26). The larger sample size shrunk the spread of the observations, but 
had little effect on the median correlation, so the scale for the y-axis ranges from 
0.2 to 0.7 for n=1000 (Figure 22-Figure 24), but is wider (ranging from 0 to 0.8) 
for n=100 to encompass the increase in variability of the estimates (Figure 25-
Figure 26). With regard to the number of imputed data sets, increasing from m=5 
to m=20 did not appear to correct the bias seen with XFCS or MNAR (Figure 24). 
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Figure 28-Figure 32 show the CI width for the correlation estimates. Focusing 
on the MCAR results, the distribution of CI width was not symmetric, with up to 
4% of the larger values considered outliers. The CI’s were wider and the 
variability increased as the amount of missing data increased. The three 
longitudinal imputation methods showed lower CI width (0.09 for HAI5 vs HAI6 
versus 0.10 for HAI7 vs HAI8) as compared to XFCS (0.16) across all panels 
(Figure 29). As expected, the CI’s were much wider (0.28-0.52) for n=100 (Figure 
31) vs n=1000 (0.09-0.16), so the scale for the figures differs based on sample 
size. The variability in the CI width was larger for m=5 than m=20 (Figure 30). 
The coverage probabilities of the CIs are shown in Figure 33-Figure 36. As 
indicated by the correlation of HAI in Figure 22, the XFCS method consistently 
underestimated the correlation, and the corresponding coverage probability was 
always zero (Figure 33). The longitudinal methods all performed similarly when 
estimating the correlation between two adjacent exams (see the first panel in 
each row and the last panel in the second row). For non-adjacent exams, 2fFCS 
performed worse (0.01-0.30 lower coverage probability) than the other two 
longitudinal methods (see the last two panels in the top row and the middle panel 
in the bottom row). The coverage probabilities for CC analysis were about the 
same as for LFCS and AFCS, and worse than all of the longitudinal methods with 
data MNAR. Finally, the coverage probabilities for data MNAR were slightly lower 
than for other missing data mechanisms, with noticeably lower values for 2fFCS 
at non-adjacent exams. 
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Similar to the coverage probability of the means, there was little effect of 
using 20 imputed datasets instead of 5, but the coverage probability was 
improved for smaller (n=100) vs larger sample sizes (n=1000) due to the 
increase in the CI width (Figure 34-Figure 36). This was apparent for XFCS, as 
the coverage probabilities range from 0.04 to 0.74 for n=100 and m=5 (Figure 
35), instead of all being zero, as they were for n=1000. There was little difference 
between coverage probabilities for the different mechanisms for the three 
longitudinal imputation methods, however, the coverage probabilities for XFCS 
were highest for MCAR, slightly lower for MAR, and even lower for MNAR in all 
six panels (Figure 35). 
The RE was also asymmetric and it was inversely related to the CI width. The 
RE was not affected by sample size, but it did increase by 2-5% when moving 
from m=5 to m=20 (Figure 37-Figure 40). Figure 37 and Figure 40 cover a larger 
range on the y-axis (0.85 to 1.00) for m=5, as compared to the scale for m=20 
(0.97 to 1.00). The improvement in using m=20 vs m=5 appeared to increase as 
the amount of missing data increased (Figure 41). The results were similar for all 
three missing data mechanisms. The average RE improved and the spread of 
the CI width shrunk by increasing from 5 to 20 imputed data sets. 
Assessment of Slopes 
Figure 42-Figure 43 shows the slope of the HAI across exams, as calculated 
in LME models. The figures are set up similar to those for means and 
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correlations. There is one figure for each sample size, and within each figure 
there are two panels representing the number of imputed datasets (5 and 20). 
Each panel shows three groups of boxplots for the three types of missing data 
mechanisms, and finally within each group, there are four boxplots representing 
the different imputation methods. The lines across the panels represent the CC 
estimates, with the green line for the MCAR estimate coinciding with the gray line 
for the full data estimate (they are both 0.15). 
The MCAR results showed that all four imputation methods and the CC 
analysis produced unbiased estimates for the slope. The three longitudinal 
imputation methods also produced unbiased estimates when the data are MAR, 
but the CC analysis and XFCS method underestimated the slope (38% bias). 
When the data were MNAR, the three longitudinal methods performed similarly, 
underestimating the slope with 82 to 88% bias, with some improvement over the 
CC analysis. XFCS underestimated the slope with 155% bias, performing worse 
than the CC analysis and estimating a negative slope, or decrease in HAI over 
time. The results were very similar for m=5 and m=20 (Figure 42). Similar 
patterns emerged when n=100, though the differences were less extreme (Figure 
43). 
The CI widths for the slope of HAI are shown in Figure 44 (n=1000) and 
Figure 45 (n=100). The CI widths were similar for all three missing data 
mechanisms in the first panel where m=5 (Figure 44). The three longitudinal 
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imputation methods had average widths of 0.78-0.80, whereas XFCS had wider 
CIs with a small decrease in CI width for MNAR (0.095) as compared with MCAR 
(0.100) and MAR (0.099). Results were very similar when looking at 20 imputed 
datasets. The CIs were wider for n=100 due to the decrease in sample size 
(Figure 45). LFCS also tended to be narrower than the other longitudinal 
imputation methods, by a small margin (0.005-0.017 smaller width). XFCS still 
had the widest CIs. 
The coverage probabilities were unaffected by the number of imputed 
datasets, and they were higher for lower sample sizes in certain situations 
(Figure 46-Figure 47). For data MCAR, the coverage probabilities were all in the 
range of 0.93-0.97, consistent with the expectations of 0.95 coverage probability 
for a 95% CI. Similar coverage probabilities were seen with MAR data, with the 
exceptions of XFCS in samples of n=1000, where coverage probabilities were 
0.31-0.36, and CC analysis with coverage probabilities of 0.81-0.90 (Figure 46). 
Finally, for data MNAR, the coverage probabilities were 0 for all imputation 
methods and CC with n=1000 (Figure 46). When n=100, they ranged from 0.46-
0.6 for the longitudinal methods and 0.12-0.17 for XFCS (Figure 47). 
As I saw with the means and correlations, the number of imputed datasets 
influenced RE, while sample size had no effect on it. Therefore, the plots for RE 
represent the different number of imputed datasets, with separate panels in each 
figure for the different sample sizes. When the data were MCAR the three 
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longitudinal methods performed similarly, while XFCS had slightly lower RE 
(0.937 vs 0.948-0.949), as seen in the first panel with n=1000 and m=5 (Figure 
48). The results were very similar for MAR, and all of the imputation methods had 
similar, but lower RE when the data were MNAR (0.940-0.942, Figure 48). The 
second panel shows very similar results when n=100. 
The RE was higher and had less variability with more imputed datasets 
(Figure 49). The y-axis ranged from 0.97 to 0.995, as opposed to 0.85 to 1.00 
when m=5. As with 20 imputed datasets, the three longitudinal methods had 
higher RE than XFCS for data MCAR or MAR when the number of imputed 
datasets increased to 20. For data MNAR, all four imputation methods had the 
same RE (0.985-0.986). 
Convergence 
I calculated ?̂? for all four imputation methods with n=1000 and m=5 and 
showed average results for all datasets masked MAR with 10 and 100 iterations 
(Table 19). On average, all of the HAI components converged with the default 10 
iterations for XFCS (?̂?𝑐 < 1.04 for MAR, ?̂?𝑐 < 1.05 for MCAR, and ?̂?𝑐 < 1.04 for 
MNAR). The longitudinal methods all had convergence issues with FVC. The ?̂?𝑐 
was greater than the recommended cutoff value of 1.2 for FVC at exams 5-7 for 
AFCS and LFCS with ten iterations, and at all exams for 2fFCS. ?̂?𝑐 remained 
greater than 1.2 for FVC at exams 5 and 6 with 100 iterations for all three 
longitudinal imputation methods.  
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Results were similar for other datasets. Generally, there was better 
convergence for data masked MCAR and more convergence issues for data 
masked MNAR (data not shown). 
FHS Application 
I ran the four MI methods on the FHS HAI data to see how the results 
compared with CC analysis for means, correlations and slope of the HAI over 
time. 
Means 
The mean HAI values at each exam for CC and using each imputation 
method are shown in Table 20. The CC analysis had the lowest mean HAI 
across all exams, with standard errors inflated 1-13% as compared with all 
imputation methods. Similar to the simulation study, all three longitudinal 
imputation methods produced similar results, whereas XFCS estimated slightly 
higher mean HAI values, with comparable standard errors. The RE estimates 
ranged from 0.977 (XFCS at exam 8) to 0.999 for m=5. There was no change in 
estimates or standard error, and I saw only minimal gain in RE when using 20 
imputed datasets instead of 5. 
Correlations 
Table 21 shows the correlation of HAI between pairs of FHS exams in 
complete cases, as well as with imputed data. As expected from the simulation 
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study, XFCS produced lower correlations than longitudinal imputation methods 
and CC analysis. The longitudinal methods and CC analysis produced similar 
results, and there was not a decrease in correlation for non-adjacent exams as 
seen in the simulation study. The CI width (calculated based on Fisher’s z-
transformation) was similar for all imputation methods (0.09-0.11), but it was 
lower in CC analysis (0.04-0.07). The results for estimates and CI widths were 
similar for 5 and 20 imputed datasets. The RE was high for all imputation 
methods, with minimal gain when using 20 imputed datasets over 5 (≥0.94 for 
m=5 and ≥0.98 for m=20). 
Slopes 
In the FHS CC data, the HAI increased by 0.50 units on average between 
each successive exam, as measured by the slope, 𝑙. HAI estimates for the 
longitudinal imputation methods increased slightly more between exams (𝑙=0.54), 
and the highest estimates were from XFCS (𝑙=0.56). Standard errors and CI 
widths stayed about the same for all methods (Table 22). The RE was high for all 
methods at both m=5 and m=20. XFCS with m=5 had the lowest RE at 0.964, 
though it was improved to 0.994 with 20 imputed datasets. LFCS had the next 
lowest RE at 0.984 for m=5 and 0.996 for m=20. 2fFCS and AFCS both had REs 
greater than 0.99 for m=5 with little improvement for m=20. 
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Discussion 
Through an extensive simulation study, I have shown that XFCS is inferior to 
longitudinal imputation methods when imputing missing values for repeatedly 
measured components of a score variable. This is true regardless of missing 
data mechanism or type of analysis performed on the imputed datasets. The 
three longitudinal methods appeared to be indistinguishable, with the exception 
of 2fFCS with a time window width of one when estimating correlations of non-
adjacent exams. These three methods yield similar results, but LFCS was the 
least computationally intensive of the longitudinal methods I examined (Table 
23). 
While there were some differences in smaller samples of n=100, the overall 
conclusions were the same as for samples of n=1000. Increasing the number of 
imputed datasets from 5 to 20 yielded limited gains in RE, and showed little to no 
improvement in bias, CI width and coverage probability. Whether or not the gain 
in efficiency warrants the increase in computation time and resources is left to 
the reader/analyst (Table 23). For my study, I submit that five imputed datasets 
were sufficient. 
The convergence statistics suggested that not all of the imputation methods 
were achieving convergence for all components at all time points. However, after 
closely analyzing the between and within variances, I believe there may be some 
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limitations in applying this method in situations where the data is highly 
correlated. I discuss this further in Chapter 5. 
When I ran the four imputation methods in the actual FHS Offspring data, I 
compared the patterns in the means, correlations and slopes to the results of the 
simulation study. The CC analyses were closest to the results from the 
longitudinal imputation methods. However, in the FHS Offspring data, I did not 
see a large difference between the correlation estimates in the longitudinal 
methods compared with XFCS. This suggested some degree of the data were 
MNAR. 
Some limitations of generalizing this study include the low number (five) of 
components within this score variable, and the limited number (four) of repeated 
measurements for each individual. A different correlation structure between 
components may also lead to different results, limiting generalizability of this 
study. 
However, this study has many strengths, as well. I have shown that MI is 
feasible in this setting, and it is always comparable, if not superior, to CC 
analyses. Further evaluation of 2fFCS showed that it performed well in data 
MAR, and improved on CC analyses for data MNAR, although it still produced 
biased estimates. 
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Tables 
 Table 12. Target Correlation Matrix 
Variable 
Exam 
SBP FVC MMSE Glucose Creatinine 
5 6 7 8 5 6 7 8 5 6 7 8 5 6 7 8 5 6 7 8 
Age 5 .25 .25 .25 .25 -.30 -.20 -.25 -.30 -.35 .06 -.25 -.20 -.15 -.15 
S
B
P
 
5 1 .55 .45 .35 
-.10 0 .10 0 
6  1 .55 .45 
7   1 .55 
8    1 
F
V
C
 
5 
 
1 .97 .94 .91 
0 0 .25 .25 .20 .15 
6  1 .97 .94 
7   1 .97 
8    1 
M
M
S
E
 5 
  
1 .45 .45 .45 
-.10 -.10 
6  1 .45 .45 
7   1 .45 
8    1 
G
lu
c
o
s
e
 5 
   
1 .70 .55 .45 
.10 
6  1 .70 .55 
7   1 .70 
8    1 
C
re
a
ti
n
in
e
 5 
 
 
  
1 .65 .50 .35 
6   1 .65 .50 
7    1 .65 
8     1 
SBP=Systolic Blood Pressure; FVC=Forced Vital Capacity; MMSE=Mini-Mental Status Exam 
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Table 13. Target Means and Standard Deviations 
Variable Exam 
Males Females 
Mean SD Mean SD 
Age 5 60.4 7 60.1 7 
SBP 
5 130 19 130 19 
6 130 19 130 19 
7 130 19 130 19 
8 130 19 130 19 
FVC 
5 4 0.6 2.9 0.6 
6 3.9 0.6 2.8 0.6 
7 3.8 0.6 2.7 0.6 
8 3.7 0.6 2.6 0.6 
MMSE 
5 28 2.1 28.5 2.1 
6 28 2.1 28.5 2.1 
7 28 2.1 28.5 2.1 
8 28 2.1 28.5 2.1 
Glucose 
5 106 29 100 29 
6 108 29 102 29 
7 110 29 104 29 
8 112 29 106 29 
Creatinine 
5 1.1 0.29 0.9 0.29 
6 1.1 0.29 0.9 0.29 
7 1.1 0.29 0.9 0.29 
8 1.1 0.29 0.9 0.29 
SBP=Systolic Blood Pressure; FVC=Forced Vital Capacity; MMSE=Mini-Mental Status Exam; 
SD=Standard Deviation 
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Table 14. Thresholds Used to Group Each Component of the HAI 
Component Gender 
Score for Group 
0 1 2 
SBP 
(mm Hg) 
Both <126 126-143 ≥143 
FVC (L) 
Men ≥3.84 3.19-3.84 <3.19 
Women ≥2.61 2.14-2.61 <2.14 
MMSE 
(points) 
Both ≥27 24-27 <24 
Glucose 
(mg/dL) 
Both <100 100-125 ≥126 
Creatinine 
(mg/dL) 
Men <1.1 1.1-1.3 ≥1.3 
Women <0.8 0.8-1.0 ≥1.0 
SBP=Systolic Blood Pressure; FVC=Forced Vital Capacity; MMSE=Mini-Mental Status Exam 
 
 
  
73 
 
Table 15. Target Percent of Missing Values 
  Exam 5 Exam 6 Exam 7 Exam 8 
SBP 0 0 0 0 
FVC 15 20 25 30 
MMSE 1 1 1 1 
Glucose 5 5 5 5 
Creatinine 5 5 5 5 
Non-attendees 0 10 20 30 
     
Missing Data 
Mechanism 
HAI 
MCAR 24 36 46 56 
MAR 20 32 44 54 
MNAR 20 32 44 54 
SBP=Systolic Blood Pressure; FVC=Forced Vital Capacity; MMSE=Mini-Mental Status Exam; 
HAI=Healthy Aging Index; MCAR=Missing Completely at Random; MAR=Missing at Random; 
MNAR=Missing Not at Random 
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Table 16. Mean HAI in Full Simulated Data 
Exam Mean (SD) 
5 3.33 (1.68) 
6 3.48 (1.70) 
7 3.63 (1.74) 
8 3.79 (1.77) 
SD=Standard Deviation 
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Table 17. Correlation of HAI across Exams in Full Simulated Data 
Exam 5 6 7 8 
5 -- 0.73 0.72 0.63 
6  -- 0.78 0.66 
7   -- 0.73 
8    -- 
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Table 18. Percent Missing Values in Full Simulated Data 
Missing Data 
Mechanism 
HAI 
Exam 5 
HAI 
Exam 6 
HAI 
Exam 7 
HAI 
Exam 8 
MCAR 24 36 46 56 
MAR 20 32 43 54 
MNAR 20 32 44 53 
MCAR=Missing Completely at Random, MAR=Missing at Random, MNAR=Missing Not at 
Random, HAI=Healthy Aging Index 
  
77 
 
Table 19. Potential Scale Reduction Factor (?̂?𝒄) for Imputed Values for 
Means, Correlations and Slopes 
HAI 
Component 
Exam 
XFCS LFCS AFCS 2fFCS 
Number of Iterations 
10 100 10 100 10 100 10 100 
Systolic 
Blood 
Pressure 
5 1.03 1.01 1.03 1.01 1.04 1.01 1.10 1.01 
6 1.03 1.01 1.04 1.01 1.03 1.01 1.07 1.01 
7 1.04 1.01 1.04 1.01 1.05 1.01 1.10 1.01 
8 1.03 1.01 1.04 1.01 1.04 1.01 1.09 1.01 
Fasting 
Glucose 
5 1.04 1.01 1.05 1.01 1.04 1.01 1.11 1.01 
6 1.04 1.01 1.03 1.01 1.06 1.01 1.12 1.01 
7 1.03 1.01 1.05 1.01 1.05 1.01 1.14 1.01 
8 1.03 1.01 1.05 1.01 1.05 1.01 1.07 1.01 
Mini-Mental 
State Exam 
5 1.03 1.01 1.04 1.01 1.04 1.01 1.07 1.01 
6 1.03 1.01 1.04 1.01 1.04 1.01 1.08 1.01 
7 1.03 1.01 1.04 1.01 1.04 1.01 1.07 1.01 
8 1.03 1.01 1.04 1.01 1.04 1.01 1.08 1.01 
Creatinine 
5 1.04 1.01 1.04 1.01 1.04 1.01 1.10 1.01 
6 1.04 1.01 1.05 1.01 1.04 1.01 1.12 1.01 
7 1.03 1.01 1.05 1.01 1.06 1.01 1.10 1.01 
8 1.04 1.01 1.05 1.01 1.05 1.01 1.11 1.01 
Forced 
Vital 
Capacity 
5 1.03 1.01 1.45 1.28 1.43 1.24 1.59 1.29 
6 1.03 1.01 1.42 1.25 1.44 1.23 1.54 1.26 
7 1.04 1.01 1.32 1.16 1.30 1.14 1.48 1.16 
8 1.03 1.01 1.17 1.07 1.16 1.06 1.27 1.07 
HAI=Healthy Aging Index. XFCS=Cross-sectional fully conditional specification. 
LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional specification. 
2fFCS=Two-fold fully conditional specification. Values shown are averaged over all datasets 
masked MAR with n=1000 and m=5 imputed datasets.  
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Table 20. Mean HAI in Complete Case and Imputed Data in FHS 
Imputation 
Method 
 Exam 
m 5 6 7 8 
Complete 
Case 
 n=1881 n=1840 n=1670 n=1511 
-- 2.52 (0.041) 3.98 (0.042) 3.84 (0.048) 3.92 (0.051) 
 n=2583 
XFCS 
5 2.61 (0.036) 4.06 (0.039) 4.02 (0.043) 4.12 (0.050) 
20 2.61 (0.036) 4.06 (0.038) 4.02 (0.044) 4.11 (0.049) 
LFCS 
5 2.59 (0.037) 4.03 (0.038) 3.91 (0.042) 4.02 (0.047) 
20 2.59 (0.036) 4.02 (0.038) 3.91 (0.042) 4.02 (0.048) 
AFCS 
5 2.59 (0.036) 4.02 (0.038) 3.91 (0.042) 4.03 (0.048) 
20 2.59 (0.036) 4.02 (0.038) 3.91 (0.042) 4.03 (0.048) 
2fFCS 
5 2.59 (0.036) 4.02 (0.038) 3.92 (0.042) 4.03 (0.049) 
20 2.58 (0.036) 4.02 (0.038) 3.92 (0.042) 4.03 (0.048) 
HAI=Healthy Aging Index. FHS=Framingham Heart Study. m=Number of imputed datasets. 
n=Number of observations with complete data available. XFCS=Cross-sectional fully conditional 
specification. LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional 
specification. 2fFCS=Two-fold fully conditional specification. 
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Table 21. Correlation of HAI in Complete Case and Imputed FHS Data 
Imputation 
Method 
Exams 
m 5 vs 6 5 vs 7 5 vs 8 6 vs 7 6 vs 8 7 vs 8 
Complete 
Case -- 
n=1414 n=1277 n=1152 n=1418 n=1256 n=1231 
0.73 0.72 0.63 0.78 0.66 0.73 
 n=2583 
XFCS 
5 0.70 0.64 0.59 0.73 0.63 0.69 
20 0.69 0.64 0.59 0.74 0.63 0.70 
LFCS 
5 0.72 0.69 0.62 0.77 0.65 0.71 
20 0.72 0.69 0.62 0.77 0.65 0.71 
AFCS 
5 0.72 0.69 0.63 0.77 0.65 0.72 
20 0.72 0.69 0.63 0.77 0.65 0.71 
2fFCS 
5 0.72 0.68 0.62 0.76 0.65 0.72 
20 0.72 0.68 0.62 0.77 0.65 0.71 
Values shown are Pearson correlation coefficients. HAI=Healthy Aging Index. FHS=Framingham 
Heart Study. m=Number of imputed datasets. n=Number of observations with complete data 
available. XFCS=Cross-sectional fully conditional specification. LFCS=Longitudinal fully 
conditional specification. AFCS=All fully conditional specification. 2fFCS=Two-fold fully 
conditional specification. 
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Table 22. Slope of Linear Mixed Effect Model Estimating Change in HAI 
over Time in Complete Case and Imputed FHS Data 
Imputation Method m Slope SE CI Width RE 
Complete Case -- 0.50 0.013 0.05 -- 
XFCS 
5 0.56 0.013 0.05 0.964 
20 0.56 0.012 0.05 0.994 
LFCS 
5 0.54 0.012 0.05 0.984 
20 0.54 0.012 0.05 0.996 
AFCS 
5 0.54 0.011 0.04 0.992 
20 0.54 0.011 0.04 0.997 
2fFCS 
5 0.54 0.012 0.05 0.991 
20 0.54 0.012 0.05 0.996 
HAI=Healthy Aging Index. m=Number of Imputed Datasets. SE=Standard Error. RE=Relative 
Efficiency. XFCS=Cross-sectional fully conditional specification. LFCS=Longitudinal fully 
conditional specification. AFCS=All fully conditional specification. 2fFCS=Two-fold fully 
conditional specification. 
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Table 23. Computation Times for Multiple Imputation Methods in 
Framingham Heart Study Data 
Imputation Method m Time, s 
XFCS 
5 6.32 
20 24.56 
LFCS 
5 6.07 
20 23.33 
AFCS 
5 12.25 
20 47.44 
2fFCS 
5 91.16 
20 354.90 
m=Number of Imputed Datasets. s=Seconds. XFCS=Cross-sectional fully conditional 
specification. LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional 
specification. 2fFCS=Two-fold fully conditional specification. 2fFCS was run in STATA, all other 
methods were run in SAS. 
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Figures 
Figure 5. Mean HAI across Exams for Different Missing Data Mechanisms 
and Imputation Methods with N=1000 and m=5 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. XFCS=Cross-sectional fully conditional specification. 
LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional specification. 
2fFCS=Two-fold fully conditional specification.  
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Figure 6. Mean HAI across Exams for Different Missing Data Mechanisms 
and Imputation Methods with N=1000 and m=20 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. XFCS=Cross-sectional fully conditional specification. 
LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional specification. 
2fFCS=Two-fold fully conditional specification.  
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Figure 7. Mean HAI across Exams for Different Missing Data Mechanisms 
and Imputation Methods with N=100 and m=5 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. XFCS=Cross-sectional fully conditional specification. 
LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional specification. 
2fFCS=Two-fold fully conditional specification.  
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Figure 8. Mean HAI across Exams for Different Missing Data Mechanisms 
and Imputation Methods with N=100 and m=20 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. XFCS=Cross-sectional fully conditional specification. 
LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional specification. 
2fFCS=Two-fold fully conditional specification. 
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Figure 9. Confidence Interval Width for Mean HAI across Exams for 
Different Missing Data Mechanisms and Imputation Methods with N=1000 
and m=5 
 
HAI=Healthy Aging Index. CI=Confidence Interval. MCAR=Missing Completely at Random. 
MAR=Missing at Random. MNAR=Missing Not at Random. XFCS=Cross-sectional fully 
conditional specification. LFCS=Longitudinal fully conditional specification. AFCS=All fully 
conditional specification. 2fFCS=Two-fold fully conditional specification.  
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Figure 10. Confidence Interval Width for Mean HAI across Exams for 
Different Missing Data Mechanisms and Imputation Methods with N=1000 
and m=20 
 
HAI=Healthy Aging Index. CI=Confidence Interval. MCAR=Missing Completely at Random. 
MAR=Missing at Random. MNAR=Missing Not at Random. XFCS=Cross-sectional fully 
conditional specification. LFCS=Longitudinal fully conditional specification. AFCS=All fully 
conditional specification. 2fFCS=Two-fold fully conditional specification.  
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Figure 11. Confidence Interval Width for Mean HAI across Exams for 
Different Missing Data Mechanisms and Imputation Methods with N=100 
and m=5 
 
HAI=Healthy Aging Index. CI=Confidence Interval. MCAR=Missing Completely at Random. 
MAR=Missing at Random. MNAR=Missing Not at Random. XFCS=Cross-sectional fully 
conditional specification. LFCS=Longitudinal fully conditional specification. AFCS=All fully 
conditional specification. 2fFCS=Two-fold fully conditional specification.  
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Figure 12. Confidence Interval Width for Mean HAI across Exams for 
Different Missing Data Mechanisms and Imputation Methods with N=100 
and m=20 
 
HAI=Healthy Aging Index. CI=Confidence Interval. MCAR=Missing Completely at Random. 
MAR=Missing at Random. MNAR=Missing Not at Random. XFCS=Cross-sectional fully 
conditional specification. LFCS=Longitudinal fully conditional specification. AFCS=All fully 
conditional specification. 2fFCS=Two-fold fully conditional specification. 
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Figure 13. Coverage Probability of Confidence Intervals for Mean HAI 
across Exams for Different Missing Data Mechanisms and Imputation 
Methods with N=1000 and m=5 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. CC=Complete case. XFCS=Cross-sectional fully conditional 
specification. LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional 
specification. 2fFCS=Two-fold fully conditional specification. 
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Figure 14. Coverage Probability of Confidence Intervals for Mean HAI 
across Exams for Different Missing Data Mechanisms and Imputation 
Methods with N=1000 and m=20 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. CC=Complete Case. XFCS=Cross-sectional fully conditional 
specification. LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional 
specification. 2fFCS=Two-fold fully conditional specification.  
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Figure 15. Coverage Probability of Confidence Intervals for Mean HAI 
across Exams for Different Missing Data Mechanisms and Imputation 
Methods with N=100 and m=5 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. CC=Complete Case. XFCS=Cross-sectional fully conditional 
specification. LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional 
specification. 2fFCS=Two-fold fully conditional specification.  
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Figure 16. Coverage Probability of Confidence Intervals for Mean HAI 
across Exams for Different Missing Data Mechanisms and Imputation 
Methods with N=100 and m=20 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. CC=Complete Case. XFCS=Cross-sectional fully conditional 
specification. LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional 
specification. 2fFCS=Two-fold fully conditional specification.  
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Figure 17. Relative Efficiency for Mean HAI across Exams for Different 
Missing Data Mechanisms and Imputation Methods with N=1000 and m=5 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. XFCS=Cross-sectional fully conditional specification. 
LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional specification. 
2fFCS=Two-fold fully conditional specification.  
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Figure 18. Relative Efficiency for Mean HAI across Exams for Different 
Missing Data Mechanisms and Imputation Methods with N=1000 and m=20 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. XFCS=Cross-sectional fully conditional specification. 
LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional specification. 
2fFCS=Two-fold fully conditional specification.  
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Figure 19. Relative Efficiency for Mean HAI across Exams for Different 
Missing Data Mechanisms and Imputation Methods with N=100 and m=5 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. XFCS=Cross-sectional fully conditional specification. 
LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional specification. 
2fFCS=Two-fold fully conditional specification.  
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Figure 20. Relative Efficiency for Mean HAI across Exams for Different 
Missing Data Mechanisms and Imputation Methods with N=100 and m=20 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. XFCS=Cross-sectional fully conditional specification. 
LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional specification. 
2fFCS=Two-fold fully conditional specification.  
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Figure 21. Percent Missing Data and Relative Efficiency of Mean of HAI 
across Exams in Samples of n=1000 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. XFCS=Cross-sectional fully conditional specification. 
LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional specification. 
2fFCS=Two-fold fully conditional specification.  
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Figure 22. Correlation of HAI across Exams in Samples of n=1000 and Data 
Imputed with m=5 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. XFCS=Cross-sectional fully conditional specification. 
LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional specification. 
2fFCS=Two-fold fully conditional specification.  
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Figure 23. Alternate View of Correlation of HAI across Exams in Samples of 
n=1000 and Data Imputed with m=5 
 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. XFCS=Cross-sectional fully conditional specification. 
LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional specification. 
2fFCS=Two-fold fully conditional specification.  
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Figure 24. Correlation of HAI across Exams in Samples of n=1000 and Data 
Imputed with m=20 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. XFCS=Cross-sectional fully conditional specification. 
LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional specification. 
2fFCS=Two-fold fully conditional specification.  
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Figure 25. Correlation of HAI across Exams in Samples of n=100 and Data 
Imputed with m=5 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. XFCS=Cross-sectional fully conditional specification. 
LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional specification. 
2fFCS=Two-fold fully conditional specification.  
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Figure 26. Correlation of HAI across Exams in Samples of n=100 and Data 
Imputed with m=20 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. XFCS=Cross-sectional fully conditional specification. 
LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional specification. 
2fFCS=Two-fold fully conditional specification.  
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Figure 27. Comparing 2fFCS with Time Window Width of One Exam vs Two 
Exams 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. 2fFCS=Two-fold fully conditional specification.  
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Figure 28. Confidence Interval Width of Correlation of HAI across Exams in 
Samples of n=1000 and Data Imputed with m=5 
 
HAI=Healthy Aging Index. CI=Confidence Interval. MCAR=Missing Completely at Random. 
MAR=Missing at Random. MNAR=Missing Not at Random. XFCS=Cross-sectional fully 
conditional specification. LFCS=Longitudinal fully conditional specification. AFCS=All fully 
conditional specification. 2fFCS=Two-fold fully conditional specification.  
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Figure 29. Alternate View of Confidence Interval Width of Correlation of HAI 
across Exams in Samples of n=1000 and Data Imputed with m=5 
 
 
HAI=Healthy Aging Index. CI=Confidence Interval. MCAR=Missing Completely at Random. 
MAR=Missing at Random. MNAR=Missing Not at Random. XFCS=Cross-sectional fully 
conditional specification. LFCS=Longitudinal fully conditional specification. AFCS=All fully 
conditional specification. 2fFCS=Two-fold fully conditional specification.  
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Figure 30. Confidence Interval Width of Correlation of HAI across Exams in 
Samples of n=1000 and Data Imputed with m=20 
 
HAI=Healthy Aging Index. CI=Confidence Interval. MCAR=Missing Completely at Random. 
MAR=Missing at Random. MNAR=Missing Not at Random. XFCS=Cross-sectional fully 
conditional specification. LFCS=Longitudinal fully conditional specification. AFCS=All fully 
conditional specification. 2fFCS=Two-fold fully conditional specification.  
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Figure 31. Confidence Interval Width of Correlation of HAI across Exams in 
Samples of n=100 and Data Imputed with m=5 
 
HAI=Healthy Aging Index. CI=Confidence Interval. MCAR=Missing Completely at Random. 
MAR=Missing at Random. MNAR=Missing Not at Random. XFCS=Cross-sectional fully 
conditional specification. LFCS=Longitudinal fully conditional specification. AFCS=All fully 
conditional specification. 2fFCS=Two-fold fully conditional specification.  
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Figure 32. Confidence Interval Width of Correlation of HAI across Exams in 
Samples of n=100 and Data Imputed with m=20 
 
HAI=Healthy Aging Index. CI=Confidence Interval. MCAR=Missing Completely at Random. 
MAR=Missing at Random. MNAR=Missing Not at Random. XFCS=Cross-sectional fully 
conditional specification. LFCS=Longitudinal fully conditional specification. AFCS=All fully 
conditional specification. 2fFCS=Two-fold fully conditional specification. 
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Figure 33. Coverage Probability of Confidence Intervals for Correlation of 
HAI across Exams for Different Missing Data Mechanisms and Imputation 
Methods with N=1000 and m=5 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. XFCS=Cross-sectional fully conditional specification. 
LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional specification. 
2fFCS=Two-fold fully conditional specification.  
111 
 
Figure 34. Coverage Probability of Confidence Intervals for Correlation of 
HAI across Exams for Different Missing Data Mechanisms and Imputation 
Methods with N=1000 and m=20 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. XFCS=Cross-sectional fully conditional specification. 
LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional specification. 
2fFCS=Two-fold fully conditional specification.  
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Figure 35. Coverage Probability of Confidence Intervals for Correlation of 
HAI across Exams for Different Missing Data Mechanisms and Imputation 
Methods with N=100 and m=5 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. XFCS=Cross-sectional fully conditional specification. 
LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional specification. 
2fFCS=Two-fold fully conditional specification.  
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Figure 36. Coverage Probability of Confidence Intervals for Correlation of 
HAI across Exams for Different Missing Data Mechanisms and Imputation 
Methods with N=100 and m=20 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. XFCS=Cross-sectional fully conditional specification. 
LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional specification. 
2fFCS=Two-fold fully conditional specification. 
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Figure 37. Relative Efficiency of Correlation of HAI across Exams in 
Samples of n=1000 and Data Imputed with m=5 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. XFCS=Cross-sectional fully conditional specification. 
LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional specification. 
2fFCS=Two-fold fully conditional specification. 
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Figure 38. Relative Efficiency of Correlation of HAI across Exams in 
Samples of n=1000 and Data Imputed with m=20 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. XFCS=Cross-sectional fully conditional specification. 
LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional specification. 
2fFCS=Two-fold fully conditional specification. 
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Figure 39. Relative Efficiency of Correlation of HAI across Exams in 
Samples of n=100 and Data Imputed with m=5 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. XFCS=Cross-sectional fully conditional specification. 
LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional specification. 
2fFCS=Two-fold fully conditional specification. 
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Figure 40. Relative Efficiency of Correlation of HAI across Exams in 
Samples of n=100 and Data Imputed with m=20 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. XFCS=Cross-sectional fully conditional specification. 
LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional specification. 
2fFCS=Two-fold fully conditional specification. 
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Figure 41. Percent Missing Data and Relative Efficiency of Correlation of 
HAI across Exams in Samples of n=1000 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. XFCS=Cross-sectional fully conditional specification. 
LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional specification. 
2fFCS=Two-fold fully conditional specification. 
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Figure 42. Slope of Linear Mixed Effects Models for HAI across Exams in 
Samples of n=1000 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. XFCS=Cross-sectional fully conditional specification. 
LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional specification. 
2fFCS=Two-fold fully conditional specification. 
  
120 
 
Figure 43. Slope of Linear Mixed Effects Models for HAI across Exams in 
Samples of n=100 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. XFCS=Cross-sectional fully conditional specification. 
LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional specification. 
2fFCS=Two-fold fully conditional specification. 
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Figure 44. Confidence Interval Width for Slope of Linear Mixed Effects 
Models for HAI across Exams in Samples of n=1000 
 
HAI=Healthy Aging Index. CI=Confidence Interval. MCAR=Missing Completely at Random. 
MAR=Missing at Random. MNAR=Missing Not at Random. XFCS=Cross-sectional fully 
conditional specification. LFCS=Longitudinal fully conditional specification. AFCS=All fully 
conditional specification. 2fFCS=Two-fold fully conditional specification. 
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Figure 45. Confidence Interval Width for Slope of Linear Mixed Effects 
Models for HAI across Exams in Samples of n=100 
 
HAI=Healthy Aging Index. CI=Confidence Interval. MCAR=Missing Completely at Random. 
MAR=Missing at Random. MNAR=Missing Not at Random. XFCS=Cross-sectional fully 
conditional specification. LFCS=Longitudinal fully conditional specification. AFCS=All fully 
conditional specification. 2fFCS=Two-fold fully conditional specification. 
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Figure 46. Coverage Probability of Confidence Intervals for Slope of Linear 
Mixed Effects Models for HAI across Exams for Different Missing Data 
Mechanisms and Imputation Methods with N=1000 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. XFCS=Cross-sectional fully conditional specification. 
LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional specification. 
2fFCS=Two-fold fully conditional specification. 
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Figure 47. Coverage Probability of Confidence Intervals for Slope of Linear 
Mixed Effects Models for HAI across Exams for Different Missing Data 
Mechanisms and Imputation Methods with N=100 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. XFCS=Cross-sectional fully conditional specification. 
LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional specification. 
2fFCS=Two-fold fully conditional specification. 
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Figure 48. Relative Efficiency for Slope of Linear Mixed Effects Models for 
HAI across Exams with m=5 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. XFCS=Cross-sectional fully conditional specification. 
LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional specification. 
2fFCS=Two-fold fully conditional specification. 
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Figure 49. Relative Efficiency for Slope of Linear Mixed Effects Models for 
HAI across Exams with m=20 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. XFCS=Cross-sectional fully conditional specification. 
LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional specification. 
2fFCS=Two-fold fully conditional specification. 
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CHAPTER 4 – SURVIVAL MODELS 
Introduction 
Motivation 
The motivating project behind this thesis focused on whether the HAI predicts 
mortality in survival models. Since HAI — a score variable measured repeatedly 
over time — had up to 30% missing data at baseline, and up to 45% missing data 
at later exams, it was important to compare imputation methods in the survival-
analysis setting.  
Overview 
I begin this chapter by describing the methods of my simulation study, 
focusing on the parts that differ from Chapter 3. I describe how I simulated the 
data, specifically the survival times conditional on HAI, sex and age. Next, I 
masked some data for death, censoring and other reasons. In each stage, I used 
Framingham Offspring data to provide parameter values for HAI components, 
survival times and censoring. With masked data, I used the four methods of 
multiple imputation described previously. To each imputed dataset, I fitted 
survival models using covariates sex, age and time-dependent HAI.  
In the results section, I briefly discuss the similarities between type I and 
random censoring. Then, I show the often used carry-forward method of time-
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dependent variable analysis is inferior to complete case analysis and MI. I look at 
the convergence of each HAI component at all time points in each imputation 
method. Finally, I show the results of using each MI method in the motivating 
FHS Offspring data.  
I end the chapter with a full discussion of the results in survival models. I 
compare each of the analysis and imputation methods. Then I describe all of the 
steps I took to better understand the minimal bias that is introduced when using 
MI in time-dependent variable survival models. I discuss the limitations of the 
potential scale reduction factor (PSRF) as a method of monitoring convergence 
in this setting, and describe the results of using the MI methods in the FHS 
Offspring data.  
Methods 
Simulation 
I used the following approach for simulation, masking, imputation and 
analysis:  
1. Simulate component data and construct HAI scores at four consecutive 
exams. 
2. Define five-year windows between consecutive exams with five years 
follow up after the last exam. 
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3. Simulate survival times using a piece-wise exponential model where sex 
and age are fixed but HAI is time-dependent (exam-specific). 
4. Apply censoring to survival times (type I and random). 
5. Mask some data for death, censoring, non-attendance and within-exam 
missingness. 
6. Impute data using four MI methods, as before. 
7. Fit proportional hazards (Cox) regression models to real data and imputed 
data.  
I simulated data for the HAI components, age and sex using the approach 
described in Chapter 3. With age, sex and HAI at each exam, I added variables 
for mortality and survival time using piece-wise exponential models. Briefly, I 
simulated time-to-event for each 5-year time, using parameter values that 
correspond with Framingham data. Here, {𝑡1, 𝑡2, 𝑡3, 𝑡4} denoted survival times 
after each exam, where 𝑡𝑖𝑗~𝐸𝑥𝑝(𝜆𝑖𝑗) was specific to period 𝑖 and person 𝑗, who 
had covariate values 𝑋𝑖𝑗 = (age at baseline, sex (M=0, F=1), HAI at exam 𝑗) and 
where 𝜆𝑖𝑗 =  𝜆𝑖𝑒𝑥𝑝(𝑋𝑖𝑗𝛽). The coefficients 𝜆𝑖𝑗 and 𝛽 were constants. Since I used 
five-year inter-exam windows, I imposed the constraints 𝑡𝑖 = min (𝑡𝑖, 5), and 𝑡𝑖 +
1 = 0 if any 𝑡𝑖 < 5, such that overall survival time was 𝑇 = 𝑡1 + 𝑡2 + 𝑡3 + 𝑡4. 
I was interested in two types of censoring: type I and random. To impose type 
I censoring, observations with T > 20 years were censored at 20 years. In a 
second scenario, I incorporated random censoring: using a Uniform(0,1) variable, 
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𝑋, I created a censoring time, 𝑐, that gave expected censoring for 5% of 
observations in each of the first three time windows, and 60% of observations in 
the last time window. The cumulative distribution function for the piece-wise 
uniform censoring time, 𝑐, is shown in (Figure 50). I calculated 𝑐 as follows: 
1. 𝜔 = 100 ∗ 𝑥; 
2. If 𝑥 < 0.15 then 𝑐 = 𝜔;  
3. If 𝑥 ≥ 0.15 then 𝑐 = 15 +
𝜔−15
12
. 
This reflects observed censoring in the FHS offspring cohort. Time to event or 
censoring was 𝑇∗ = min(𝑇, 𝑐) and the event indicator was set to 1 (for event) or 0 
(for censoring). Any observation with 𝑇∗ > 20 was censored at 20 years. I 
calibrated the piece-wise exponential models to achieve roughly 32% mortality. 
As in Chapter 3, I simulated a complete dataset of one million observations 
and randomly divided it into 1,000 samples of n=1,000. I also randomly selected 
1,000 samples of n=250 to evaluate performance in smaller samples. Due to the 
low event rate, I used samples of n=250 instead of n=100. I created separate 
datasets for type I censoring and random censoring patterns. 
Masking 
Data were masked using the same approach as described in Chapter 3, with 
the exception that non-attendance now included data missing after time of death. 
After a person’s time of death, HAI components at subsequent exams were 
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masked. Additionally, I masked for non-attendance as described in Chapter 3. 
Overall, I calibrated the masking to match the percent of missing data obtained in 
Chapter 3 (Table 15).  
Imputation 
I applied and evaluated the same four methods of MI as before: cross-section 
fully conditional specification (XFCS), longitudinal fully conditional specification 
(LFCS), all fully conditional specification (AFCS) and two-fold fully conditional 
specification (2fFCS). In addition to the HAI components, each imputation model 
also contained baseline age, sex, a death indicator, and the estimated 
cumulative null hazard H0(T) for mortality to account for time-to-event/censoring. 
Statistical Analyses 
I also looked at two simple ways to incorporate longitudinal data into Cox 
proportional hazard models with time-dependent covariates: complete case (CC) 
and last-observation-carried-forward (LOCF). In both approaches, I used HAI as 
a time-dependent covariate in models adjusted for baseline age and sex.52 In the 
CC models, I update the HAI at each exam, allowing the HAI to be missing, if it is 
missing at that exam. In LOCF, I updated the HAI at each exam if it was 
available, and if it was not, I carried forward the last (most recent) observed 
value. This is a simple single imputation method that is often used despite being 
known to cause bias.53 I compared the estimated regression coefficient for HAI to 
the parameter value used in simulation (0.23226); I evaluated percent bias, 
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confidence interval (CI) width, coverage probability, and relative efficiency (RE, 
all described in Chapter 3).  
Convergence 
Since I used different imputation models than in the prior chapter, I 
reevaluated convergence of the iterations among imputed datasets in this 
chapter. I used the same method as before, and looked at potential scale 
reduction factor (PSRF), or ?̂?𝑐.
49,50  
Results 
Type I Censoring vs. Random Censoring 
Whether I applied type I censoring or random censoring, results from time-
dependent analyses were very similar. Figure 51 shows the estimated log hazard 
ratio (HR) for 1000 replicates of n=1000 and m=5 imputed datasets for type I 
censoring (left panel) and random censoring (right panel). Comparing the two 
panels, distributions of estimates were nearly identical. CC analyses were 
unbiased, and the imputed results were nearly unbiased: there was little 
distinction among the different imputation methods and missing data 
mechanisms. The CI widths also were similar for the two types of censoring 
(Figure 52), as were the relative efficiencies (Figure 53). These same patterns 
were seen regardless of the sample size and number of imputed datasets. 
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Therefore, to avoid redundancy, in the rest of this chapter, I present results only 
for type I censoring. 
Cox Proportional Hazards Models Using HAI as a Time-Dependent Covariate 
I compared the results from the CC analysis and LOCF (Table 24). For 
samples of n=1000, the CC analysis produced unbiased estimates; however, 
standard errors were inflated compared to the standard errors in the full data. I 
use the term inflated in reference to the full data standard errors throughout the 
thesis. The LOCF method had lower standard errors, but it produced very biased 
results (14-16% underestimation). The results were similar for smaller samples of 
n=250 (Table 24). 
Focusing on the time-dependent analyses with MI, all CC analyses and 
imputation methods produced unbiased, or nearly unbiased estimates of log HR, 
regardless of sample size or number of imputed datasets (Figure 54-Figure 55). 
The imputation methods introduced minimal bias (3-4% for MAR and MCAR, 5-
7% for MNAR) but reduced the standard errors 11-17%. All four imputation 
methods performed about the same, except XFCS had slightly higher standard 
errors than the longitudinal methods. The results were similar for n=250: 1-3% 
bias for MCAR, 2% for MCAR and 4-6% for MNAR (Figure 55); furthermore, 
standard errors were 11-19% lower with imputation than with CC (data not 
shown). 
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The imputation methods differed regarding CI widths. XFCS produced wider 
CIs than the longitudinal imputation methods (Figure 56-Figure 57). The average 
CI widths were similar for m=5 and m=20; variability of CI widths was lower for 
m=20. Similar patterns existed for n=1000 and n=250 (Figure 57). 
The coverage probabilities for the CIs of the log HRs are shown in Table 25. 
With MCAR data, CC analysis and all imputation methods had coverage 
probabilities near the nominal value of 0.95. There was more variation with MAR 
data and the lowest coverage probabilities were seen with MNAR data. I found 
slightly higher coverage probabilities for smaller samples, n=250 vs n=1000. The 
coverage probabilities varied from 0.927 to 0.968, indicating that all imputation 
methods maintained adequate coverage probability (i.e., near the nominal value) 
regardless of sample size, imputation method, or number of imputed datasets 
(Table 25). 
The RE was lowest for XFCS and highest for 2fFCS, with AFCS and LFCS 
intermediate (Figure 58-Figure 59). The RE was lower for m=5 imputed datasets 
(values 0.97-0.981) than for m=20 (values ≥0.991).  
Convergence 
I used the PSRF to assess convergence in the imputations I ran for the 
survival analyses and I compared the estimated ?̂?𝑐 to the cutoff value of 1.2. 
Values which exceed 1.2 indicate convergence is not achieved. I show the 
average ?̂?𝑐 across all samples masked MAR (n=1000 and m=5 imputed 
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datasets) with default 10 iterations and with 100 iterations (Table 26). With 
XFCS, all components converged with 10 iterations. With longitudinal imputation 
methods, most components converged with 10 iterations. The exceptions are 
FVC, which had the highest within component correlation (r=0.91 to 0.97), and 
creatinine and glucose with 2fFCS, both of which converged with 50 iterations 
(data not shown). FVC showed some improvement with 100 iterations (Table 26). 
FHS Application 
I ran each imputation method and analyses in the FHS data to assess 
performance in a real dataset (Table 27). LOCF yielded the lowest parameter 
estimate (31% less than the CC estimate) and lowest standard error. XFCS 
produced the highest estimates, whereas results from the three longitudinal 
methods were intermediate. Compared with CC analysis, longitudinal imputation 
methods reduced the standard errors by 16%. All imputation methods produced 
similar CI widths, and all REs were above 0.97. There was a modest increase in 
RE with m=20 imputed datasets instead of m=5, but longitudinal methods all had 
minimal increases in REs. 
Discussion 
In the time-dependent covariate analyses, the LOCF method was inferior to 
CC analysis and to MI methods. CC analysis was unbiased, but it had inflated 
standard errors; the MI methods were slightly biased, but they had lower 
standard errors. These results were not surprising. I simulated the HAI to 
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increase with age. Using LOCF, the HAI value carried forward typically will be 
smaller than the true (missing) HAI value for that time point. Therefore, with 
LOCF, I am underestimating the HAI, and correspondingly underestimating the 
association between the HAI and mortality. If I had simulated HAI with constant 
mean over time, then I would expect LOCF to be less biased. 
Evaluating Bias in Imputed Results 
All imputation methods produced some bias under all missing data 
mechanisms, yet CC analyses were unbiased. While MI was effective at reducing 
the standard error, it was surprising that it introduced bias into the parameter 
estimates. I saw similar results for type I and random censoring, and for analyses 
that used baseline HAI (data not shown) or time-dependent HAI. These factors 
likely are not the reason for the bias. 
I made several attempts to identify the source of bias in the imputed results. 
First, I compared masked values to imputed values to see whether the imputation 
methods were poorly imputing values for a single component or time point. The 
correlations between masked and imputed HAI values were highest when the 
amount of missing data was lowest (exam 5), when the data were MCAR, and for 
observations that were eventually censored. I looked at up/down classification of 
component scores (0, 1 or 2) for masked versus imputed data. FVC had the 
lowest percent of misclassified observations, MMSE had the second lowest 
percent, while the other three components performed about the same. When 
137 
 
data were MCAR or MAR, the percent of observations that were up-classified or 
down-classified in the imputed values were about the same, so I did not expect a 
large impact on the overall HAI scores. Looking at individual components did not 
clearly answer the question of why there was bias in the imputed results but not 
in the CC analysis. 
A common source of bias in MI is using an imputation model that is not 
compatible with the substantive model. The imputation model is the model used 
to create imputed values for variables with missing data. To form the imputation 
model, the analyst specifies a type of model and a set of predictors.19 The 
substantive model is the statistical analysis model that the analyst wants to use 
with the data. Bartlett et al. define compatibility as follows: “Two conditional 
models are said to be incompatible if there exists no joint model for which the 
conditionals (for relevant variables) equal these conditional models.”54 For 
example, if you use a linear model for the imputations, but you analyze the 
complete data with a linear model containing a quadratic term, the imputation 
model will be incompatible with the substantive model.55 My imputation models 
were incompatible with my substantive models, since I used linear regression to 
impute the individual HAI components, but I lumped component values into three 
groups, from which I created the HAI – the variable of interest in my substantive 
models. Despite this incompatibility, I still obtained unbiased estimates of the 
means, correlations and slopes of the HAI in Chapter 3. 
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Using a linear model to impute missing covariates for a Cox proportional 
hazards model is common; adding information on the outcome in the imputation 
model makes it compatible with the substantive model.20,55,56 However, since I 
still saw bias in the imputed results, I altered the variables representing the time-
to-event outcome in the imputation models. I looked at four alternatives to using 
the H0(T) and death indicator: 
1. Ignored outcome information completely; 
2. Used just the death indicator, and ignored time-to-event; 
3. Used death indicator and log time (instead of H0(T)); 
4. Included an interaction term for H0(T) and complete variables20 baseline 
age and sex. 
Completely ignoring the outcome information introduced more bias (8-12%). 
The other methods showed the same percent bias as the original imputation 
model containing the death indicator and H0(T). Thus, choice of variables 
representing the event in the imputation model was likely not the cause of the 
bias I observed. Bartlett et al. suggest a modification to FCS called rejection 
sampling, which they show to be effective in reducing bias when the substantive 
model is a Cox proportional hazards model.55 Mbougua et al. propose a non-
linear method using B-splines functions in the imputation model.57 However, 
these methods would require substantial additional programming and 
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computation that was not warranted with the small amounts of bias observed 
here. Further exploration of this issue is left for future work. 
Convergence 
The PSRF showed few problems with convergence in the imputed datasets 
(Table 26). The only components that had ?̂?𝑐 > 1.2 were FVC (the component 
with the highest inter-measure correlation) and creatinine (the only component 
with moderate correlation to FVC). These results were not all improved by 
increasing to 100 between imputation iterations. This could indicate that even 
100 iterations are not sufficient, or, based on the very small within- and between-
imputation variance, it is likely the PSRF does not perform well in highly 
correlated data. See Chapter 5 for a more detailed discussion. 
Summary 
Applying the imputation and analysis methods to the FHS data did not yield 
any surprises. LOCF severely under-estimated the log hazard parameter.  The 
longitudinal imputation methods performed equally, with slight over-estimates of 
the parameter, but with lower standard errors. This makes the longitudinal 
imputation methods an attractive option, even if they are slightly biased.  
LFCS was the least computationally intensive method, while 2fFCS required 
the longest running time (Table 28). Using 20 imputed datasets instead of 5 took 
approximately four times as long to run. However, the increase in 𝑚 yielded 
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similar results for all metrics except a minimal increase in RE. Therefore, I 
recommend using LFCS with 5 imputed datasets in this setting or similar ones. 
Finally, in settings with higher cross-component correlation, I would recommend 
using 2fFCS.   
141 
 
Tables 
Table 24. Comparing Complete Case Analysis vs. Last Observation Carried 
Forward Methods in Time-Dependent Survival Models 
Analysis 
Missing 
Data 
Mechanism 
N=1000 N=250 
Estimate 
(SE) 
Percent 
Bias 
Estimate (SE) 
Percent 
Bias 
Complete 
Case 
MAR 0.233 (0.043) 0% 0.237 (0.087) 2% 
MCAR 0.232 (0.043) 0% 0.233 (0.088) 0% 
MNAR 0.234 (0.043) 1% 0.234 (0.088) 1% 
Last 
Observation 
Carried 
Forward 
MAR 0.198 (0.036) -15% 0.200 (0.072) -14% 
MCAR 0.196 (0.036) -16% 0.198 (0.073) -15% 
MNAR 0.201 (0.036) -14% 0.202 (0.074) -13% 
SE=Standard Error. MAR=Missing at Random. MCAR=Missing Completely at Random. 
MNAR=Missing Not at Random. 
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Table 25. Coverage Probabilities for Estimates of Log Hazard Ratio in 
Imputed Data 
 
    
n=Sample Size. m=Number of Imputed Datasets. MCAR=Missing Completely at Random. 
MAR=Missing at Random. MNAR=Missing Not at Random. CC=Complete Case. XFCS=Cross-
sectional fully conditional specification. LFCS=Longitudinal fully conditional specification. 
AFCS=All fully conditional specification. 2fFCS=Two-fold fully conditional specification.  
Missing Data 
Mechanism 
Imputation 
Method 
n=1000 n=250 
m=5 m=20 m=5 m=20 
MCAR 
CC 0.954 0.956 
XFCS 0.950 0.951 0.951 0.953 
LFCS 0.953 0.942 0.947 0.955 
AFCS 0.951 0.945 0.952 0.958 
2fFCS 0.948 0.955 0.958 0.958 
MAR 
CC 0.947 0.953 
XFCS 0.943 0.953 0.960 0.968 
LFCS 0.953 0.936 0.966 0.947 
AFCS 0.953 0.943 0.961 0.950 
2fFCS 0.949 0.952 0.961 0.957 
MNAR 
CC 0.946 0.946 
XFCS 0.943 0.939 0.955 0.955 
LFCS 0.938 0.927 0.948 0.947 
AFCS 0.939 0.930 0.957 0.951 
2fFCS 0.940 0.935 0.963 0.958 
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Table 26. Potential Scale Reduction Factor (?̂?𝒄) to Assess Convergence in 
Imputations for Time-Dependent Survival Analyses 
HAI 
Component 
Exam 
XFCS LFCS AFCS 2fFCS 
Number of Iterations 
10 100 10 100 10 100 10 100 
Systolic 
Blood 
Pressure 
5 1.08 1.01 1.04 1.01 1.04 1.01 1.04 1.01 
6 1.10 1.01 1.08 1.01 1.06 1.01 1.04 1.01 
7 1.14 1.01 1.07 1.01 1.06 1.01 1.03 1.01 
8 1.10 1.01 1.04 1.01 1.04 1.01 1.04 1.01 
Fasting 
Glucose 
5 1.10 1.01 1.05 1.01 1.05 1.01 1.02 1.01 
6 1.19 1.02 1.09 1.02 1.07 1.02 1.03 1.01 
7 1.23 1.02 1.10 1.02 1.09 1.02 1.03 1.01 
8 1.10 1.01 1.03 1.01 1.04 1.01 1.03 1.01 
Mini-Mental 
State Exam 
5 1.08 1.01 1.04 1.01 1.04 1.01 1.03 1.01 
6 1.12 1.01 1.05 1.01 1.05 1.01 1.03 1.01 
7 1.15 1.01 1.04 1.01 1.04 1.01 1.04 1.01 
8 1.09 1.01 1.04 1.01 1.03 1.01 1.03 1.01 
Creatinine 
5 1.09 1.01 1.04 1.01 1.04 1.01 1.03 1.01 
6 1.14 1.01 1.08 1.02 1.07 1.02 1.04 1.01 
7 1.20 1.02 1.07 1.02 1.08 1.01 1.04 1.01 
8 1.11 1.01 1.04 1.01 1.03 1.01 1.04 1.01 
Forced 
Vital 
Capacity 
5 1.68 1.32 1.58 1.33 1.61 1.34 1.02 1.01 
6 1.82 1.26 1.45 1.28 1.51 1.27 1.03 1.01 
7 1.54 1.10 1.31 1.12 1.28 1.12 1.04 1.01 
8 1.17 1.02 1.09 1.03 1.07 1.02 1.03 1.01 
HAI=Healthy Aging Index. XFCS=Cross-sectional fully conditional specification. 
LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional specification. 
2fFCS=Two-fold fully conditional specification. Values shown are average for all datasets masked 
MAR with n=1000 and m=5 imputed datasets. 
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Table 27. Results from Multiple Imputation Methods in FHS Data for Time-
Dependent Survival Analysis 
Imputation Method m Estimate (SE) CI Width RE 
Complete Case -- 0.237 (0.025)   
Carry Forward -- 0.181 (0.020)   
XFCS 
5 0.261 (0.022) 0.086 0.971 
20 0.260 (0.022) 0.086 0.994 
LFCS 
5 0.242 (0.021) 0.082 0.994 
20 0.246 (0.021) 0.083 0.997 
AFCS 
5 0.253 (0.021) 0.084 0.984 
20 0.248 (0.021) 0.084 0.997 
2fFCS 
5 0.248 (0.021) 0.080 0.996 
20 0.249 (0.021) 0.083 0.997 
FHS=Framingham Heart Study. m=Number of Imputed Datasets. SE=Standard Error. 
CI=Confidence Interval. RE=Relative Efficiency. XFCS=Cross-sectional fully conditional 
specification. LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional 
specification. 2fFCS=Two-fold fully conditional specification. Estimates shown are log hazard 
ratio of HAI in a time-dependent survival analysis predicting mortality. 
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Table 28. Computation Times for Multiple Imputation Methods in 
Framingham Heart Study Data 
Imputation Method m Time, s 
XFCS 
5 8.48 
20 33.52 
LFCS 
5 8.00 
20 31.55 
AFCS 
5 14.82 
20 52.82 
2fFCS 
5 98.51 
20 399.15 
m=Number of Imputed Datasets. s=Seconds. XFCS=Cross-sectional fully conditional 
specification. LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional 
specification. 2fFCS=Two-fold fully conditional specification.  
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Figures 
Figure 50. Cumulative Distribution Function for Censoring Time in Random 
Censoring 
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Figure 51. Comparing Type I Censoring to Random Censoring for 
Parameter Estimates of Time-Dependent HAI in Imputed Results for n=1000 
and m=5 
 
HAI=Healthy Aging Index. lnHR=Log Hazard Ratio. MCAR=Missing Completely at Random. 
MAR=Missing at Random. MNAR=Missing Not at Random. XFCS=Cross-sectional fully 
conditional specification. LFCS=Longitudinal fully conditional specification. AFCS=All fully 
conditional specification. 2fFCS=Two-fold fully conditional specification. 
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Figure 52. Comparing Type I Censoring to Random Censoring for 
Confidence Interval Width of Parameter Estimates of Time-Dependent HAI 
in Imputed Results for n=1000 and m=5 
 
HAI=Healthy Aging Index. CI=Confidence Interval. MCAR=Missing Completely at Random. 
MAR=Missing at Random. MNAR=Missing Not at Random. XFCS=Cross-sectional fully 
conditional specification. LFCS=Longitudinal fully conditional specification. AFCS=All fully 
conditional specification. 2fFCS=Two-fold fully conditional specification. 
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Figure 53. Comparing Type I Censoring to Random Censoring for Relative 
Efficiency of Parameter Estimates of Time-Dependent HAI in Imputed 
Results for n=1000 and m=5 
 
HAI=Healthy Aging Index. MCAR=Missing Completely at Random. MAR=Missing at Random. 
MNAR=Missing Not at Random. XFCS=Cross-sectional fully conditional specification. 
LFCS=Longitudinal fully conditional specification. AFCS=All fully conditional specification. 
2fFCS=Two-fold fully conditional specification. 
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Figure 54. Log Hazard Ratio for HAI as a Time-Dependent Variable in Cox 
Proportional Hazard Model with Type I Censoring for n=1000 
 
HAI=Healthy Aging Index. lnHR=Log Hazard Ratio. n=Sample Size. m=Number of Imputed 
Datasets. MCAR=Missing Completely at Random. MAR=Missing at Random. MNAR=Missing Not 
at Random. XFCS=Cross-sectional fully conditional specification. LFCS=Longitudinal fully 
conditional specification. AFCS=All fully conditional specification. 2fFCS=Two-fold fully 
conditional specification. 
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Figure 55. Log Hazard Ratio for HAI as a Time-Dependent Variable in Cox 
Proportional Hazard Model with Type I Censoring for n=250 
 
HAI=Healthy Aging Index. lnHR=Log Hazard Ratio. n=Sample Size. m=Number of Imputed 
Datasets. MCAR=Missing Completely at Random. MAR=Missing at Random. MNAR=Missing Not 
at Random. XFCS=Cross-sectional fully conditional specification. LFCS=Longitudinal fully 
conditional specification. AFCS=All fully conditional specification. 2fFCS=Two-fold fully 
conditional specification. 
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Figure 56. Confidence Interval Width for the Log Hazard Ratio of HAI as a 
Time-Dependent Variable in Cox Proportional Hazard Model with Type I 
Censoring for n=1000 
 
HAI=Healthy Aging Index. CI=Confidence Interval. n=Sample Size. m=Number of Imputed 
Datasets. MCAR=Missing Completely at Random. MAR=Missing at Random. MNAR=Missing Not 
at Random. XFCS=Cross-sectional fully conditional specification. LFCS=Longitudinal fully 
conditional specification. AFCS=All fully conditional specification. 2fFCS=Two-fold fully 
conditional specification. 
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Figure 57. Confidence Interval Width for the Log Hazard Ratio of HAI as a 
Time-Dependent Variable in Cox Proportional Hazard Model with Type I 
Censoring for n=250 
 
HAI=Healthy Aging Index. CI=Confidence Interval. n=Sample Size. m=Number of Imputed 
Datasets. MCAR=Missing Completely at Random. MAR=Missing at Random. MNAR=Missing Not 
at Random. XFCS=Cross-sectional fully conditional specification. LFCS=Longitudinal fully 
conditional specification. AFCS=All fully conditional specification. 2fFCS=Two-fold fully 
conditional specification. 
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Figure 58. Relative Efficiency for the Log Hazard Ratio of HAI as a Time-
Dependent Variable in Cox Proportional Hazard Model with Type I 
Censoring for n=1000 
 
HAI=Healthy Aging Index. n=Sample Size. m=Number of Imputed Datasets. MCAR=Missing 
Completely at Random. MAR=Missing at Random. MNAR=Missing Not at Random. 
XFCS=Cross-sectional fully conditional specification. LFCS=Longitudinal fully conditional 
specification. AFCS=All fully conditional specification. 2fFCS=Two-fold fully conditional 
specification. 
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Figure 59. Relative Efficiency for the Log Hazard Ratio of HAI as a Time-
Dependent Variable in Cox Proportional Hazard Model with Type I 
Censoring for n=250 
 
HAI=Healthy Aging Index. n=Sample Size. m=Number of Imputed Datasets. MCAR=Missing 
Completely at Random. MAR=Missing at Random. MNAR=Missing Not at Random. 
XFCS=Cross-sectional fully conditional specification. LFCS=Longitudinal fully conditional 
specification. AFCS=All fully conditional specification. 2fFCS=Two-fold fully conditional 
specification.
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CHAPTER 5 
I used four methods of multiple imputation (MI), each based on fully 
conditional specification (FCS), and I compared their performance when imputing 
a multi-component score variable measured repeatedly over time. Through 
simulation studies, I showed that with MCAR and MAR data and when FCS 
imputation models incorporate longitudinal information, MI produced unbiased 
estimates of parameters – that is, means, correlations and slope over time. When 
data were MNAR, longitudinal imputation methods produced parameter 
estimates with less bias than complete case (CC) analysis. XFCS performed the 
same as CC analysis. 
Next, in survival analysis with time-dependent covariates, I showed that CC 
analysis produced unbiased estimates of the log hazard ratio (HR) regardless of 
the missing data mechanism, but yielded larger standard errors due to reduced 
sample sizes. All four MI methods gave slightly biased parameter estimates with 
lower standard errors than CC analysis. 
When I started my research, the twofold command in STATA had some 
issues: specifically, it would not run if any time-dependent variable was fully 
observed at some time points but missing at others. To work around this 
problem, I randomly masked one observed SBP value in each simulated dataset, 
and twofold ran successfully. A new STATA version fixed this problem such that 
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twofold now works even if some variables are observed completely at some time 
points but missing at others. 
Since all three longitudinal methods performed similarly, I recommend looking 
at computation time and resources when choosing among these methods (Table 
23, Table 28). The 2fFCS was the most computationally intensive method, but it 
performed no better for estimating parameters (means, correlations, slopes and 
log HRs) of the repeatedly measured score variable. Therefore, I recommend 
LFCS or AFCS. AFCS includes both cross-sectional and longitudinal variables; it 
might be more desirable when correlations among components are high. With a 
large number of components or many time points, AFCS may be more 
computationally intensive, potentially making LFCS more desirable. However, I 
think data with higher cross-component correlations and a large number of time 
points would benefit from 2fFCS.  
I used the potential scale reduction factor (PSRF) to assess convergence of 
the imputations.49 Most components had ?̂?𝑐 statistics below the recommended 
cutoff value of 1.2, but FVC and creatinine sometimes did not, even with 100 
iterations between imputed datasets. I investigated this by looking closely at 
between and within-iteration variances for all components at all time points and I 
found that all variances were small (≤0.01 on average, and approximately 0.002 
for AFCS and LFCS). For components that did not converge, within-iteration 
variances were even smaller (≤0.00008 on average), potentially causing inflated 
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PSRF statistics. Therefore, I think this statistic may not perform well when the 
variable being imputed is highly correlated with other variables in the imputation 
model. It is for future research to explore this phenomenon in detail and perhaps 
develop a suitable statistic for that setting. 
My thesis research has several strengths. I evaluated multiple FCS-based 
methods of MI to handle missing data in a novel setting — namely, a score 
variable constructed from multiple components measured repeatedly over time. I 
showed that MI methods perform well in a study of adults aged 60 and older, in 
which two or more mechanisms for missing data may apply. Further, I extended 
the existing literature on 2fFCS, showing that 2fFCS was effective in imputing 
MAR data, and it performs better than CC analysis with MNAR data. 
My thesis research also has some limitations. The HAI components represent 
different body systems and correlations among components generally are not 
high. Therefore, my findings generalize to other multi-component scores 
constructed in the same way, but not necessarily to a score that combines highly 
correlated components. Furthermore, my simulated data contained a moderate 
number of components (five) and time points (four). If the number of components 
or time points were increased, AFCS or LFCS might be more computationally 
intensive, possibly favoring 2fFCS. By focusing on FCS imputation methods, I left 
out some approaches to handle data MNAR: pattern mixture models,8,58-60 
inverse probability weighting,61 an augmented CC analysis approach,54 protective 
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estimation,62 and sample selection methods.63,64 To my knowledge, these 
methods have not been evaluated in the situation of a multi-component score 
measured repeatedly over time. 
Next steps to extend this work would include examining different correlation 
structures, expanding the number of components and time points, and evaluating 
non-FCS imputation methods, especially for data MNAR. The recommended 
imputation method is likely to vary with different correlation structures and an 
increase in the number of components and time points.  
It would also be interesting to evaluate the effect of adding additional 
variables to the imputation models. In Chapter 2, I used several auxiliary 
variables in the imputation model. These variables included known risk factors for 
mortality and CVD, as well as strong correlates for individual HAI components. I 
think XFCS could be improved by bringing in variables correlated with the HAI 
components, if those additional variables were also included in the analysis 
model. 
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